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ABSTRACT 
 
ALTERED DEVELOPMEMENTAL PROGRAMMING OF THE MOUSE 
MAMMARY GLAND IN FEMALE OFFSPRING FOLLOWING PERINATAL 
DIETARY EXPOSURES: A SYSTEMS-BIOLOGY PERSPECTIVE 
 
CALEB DEEN BASTIAN 
 
November 21st, 2008 
 
Mishaps in prenatal development can influence mammary gland development 
and, ultimately, affect susceptibility to factors that cause breast cancer. This research was 
based on the underlying hypothesis that maternal dietary composition during pregnancy 
can alter developmental (fetal) programming of the mammary gland.We used a 
computational systems-biology approach and Bayesian-based stochastic search variable 
selection algorithm (SSVS) to identify differentially expressed genes and biological 
themes and pathways. Postnatal growth trajectories and gene expression in the mammary 
gland at 10-weeks of age in female mice were investigated following different maternal 
diet exposures during prenatal-lactational-early-juvenile development. This correlated a 
decrease in expression of energy pathways with a reciprocal increase in cytokine and 
inflammatory-signaling pathways. These findings suggest maternal dietary fat exposure 
significantly influences postnatal growth trajectories, metabolic programming, and 
signaling networks in the mammary gland of female offspring. In addition, the 
adipocytokine pathway may be a sensitive trigger to dietary changes and may influence 
or enhance activation of an immune response, a key event in cancer development.  
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1. INTRODUCTION 
 
 Over fifteen years ago, Barker and colleagues hypothesized that adverse 
environmental factors in early life, particularly nutritional deficiencies, disrupt fetal 
growth and development, leading to a more susceptible adult phenotype prone to 
cardiovascular disease (Barker, Bull et al. 1990; Dobbing 1993; Barker 1995). After a 
worldwide series of epidemiological studies, in which fetal growth restriction was 
demonstrated to be correlated with chronic disease in adulthood, this hypothesis became 
known as the developmental origins of health and disease (DOHAD) or Barker 
hypothesis. It states that environmental factors act in early life to program the risks for 
major chronic diseases, such as cardiovascular disease, stroke, hypertension, type 2 
diabetes, and obesity later in life. 
 It is well recognized that during development, there are critical periods of 
vulnerability to suboptimal conditions when developmental programming may 
permanently modify disease susceptibility (Lucas 1998). Developmental programming 
involves structural changes in important organs: altered cell number, imbalance in 
distribution of different cell types within the organ, and altered blood supply or receptor 
numbers (Armitage, Khan et al. 2004). Tissues that have been identified as targets for 
programming include heart, kidney, liver, pancreas, and adipocytes (McMillen and 
Robinson 2005). For the mammary gland, data on developmental programming are still 
limited. Changes in maternal diet have been demonstrated to alter mammary gland 
 2 
differentiation (Hilakivi-Clarke, Stoica et al. 1998; De Assis and Hilakivi-Clarke 2006). 
This might influence further development of the mammary gland and, ultimately, play an 
important role in determining later risk to breast cancer through epigenetic mechanisms 
(i.e. ubiquitinization, phosphorylation, chromatin methylation, histone acetylation, 
sumovlation).  A link between maternal nutrition in pregnancy and breast cancer risk in 
adult life has been proposed but not established. 
The goal of the study presented here was to identify cellular-response pathways 
underlying fetal programming of the murine mammary gland by nutrition. The Barker 
hypothesis has mainly focussed on the impact of maternal undernutrition. However, 
maternal and postnatal nutrition are either sufficient or excessive in developed countries. 
In fact, not only undernutrition, but also a disbalance of nutrition in the opposite direction 
correlates with adult diseases, such as cancer. Breast cancer incidence rates are about 
fourfold higher in Europe and North America than in Asia and Africa (Hortobagyi, de la 
Garza Salazar et al. 2005; Parkin, Bray et al. 2005). Besides other lifestyle factors, 
consumption of a Western diet, and more specifically dietary fat intake, has been 
demonstrated to be a major risk factor (Kato, Tominaga et al. 1987; Mattisson, Wirfalt et 
al. 2004; Binukumar and Mathew 2005). Epidemiological studies have suggested a 
positive relation between dietary fat intake and breast cancer risk (Howe, Hirohata et al. 
1990; Prentice and Sheppard 1990; Boyd, Stone et al. 2003), and this has also been 
demonstrated in rodents. Here, we investigated the effect of different perinatal diet 
exposures, using high-fat diets high in n-6 or in n-3 polyunsaturated fatty acids, on 
programming of the murine mammary gland (Figure 1) by studying gene expression 
profiles in relation to body weight trajectories. This thesis comprises a computational 
 3 
analysis of a recent dataset from a collaboration between the University of Louisville and 
RIVM, the Netherlands. 
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Figure 1. Mouse mammary tree 
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2. THEORY (Singh, Rouchka et al. 2007) 
2.1. Systems Biology Research Strategies 
 
Systems biology is an interdisciplinary science that aims at system-level 
understanding of biological systems (biosystems). It has been only recently, through 
progress in the human genome project and advancement of newer technologies for high-
content data generation, that a system-level analysis has been enabled at the molecular 
level. Grounded in the coupling of experimentation (in vivo, in vitro) with computation 
(in silico), this approach has applications toward building predictive models that are 
integrative, quantitative, and dynamic in nature. A general workflow paradigm is 
diagrammed in Figure 2 .  
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Figure 2. Workflow for inference and prediction in a systems biology paradigm 
Biological attributes observed from hypothesis-driven studies on the natural system are 
used to make inferences at different informational levels; this information is used to 
formalize the system with mathematical models. These models are tested with simulated 
and empirical data to then predict behaviors in the natural system. The process is iterated 
to improve performance and accuracy (adapted with permission from Dr. Wolkenhauer). 
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To integrate a biological system both top-down and bottom-up strategies must be 
considered. The former starts with the system as a whole and decomposes it to smaller 
modular entities, e.g., phenotypes molecules. The strength in a top-down view of birth 
defects is that overall knowledge of the system can be broken down based on clinical 
phenotype, independently of detailed molecular knowledge. The weakness, however, is 
that not all critical components or interactions may be known at the cellular and 
molecular levels. A bottom-up strategy rather starts with basic entities (genes, proteins) 
and integrates them into relevant patterns and functions (pathways, networks). The 
strength in this approach is that detailed molecular knowledge is available for a large 
number of molecular entities, and the weakness is the limited capacity to project the 
effect of perturbations in pathway models onto the cell as a whole. 
Given that a cell is the basic functional unit of a tissue, an ideal modeling 
framework should serve both strategies by providing a perspective that can be scalable 
down to the level of individual genes and scalable up to the level of the developing 
system or embryo. Fundamental epistemological issues facing systems biology were 
explored by O'Malley and Dupré in their recent BioEssay article (2005). These authors 
discuss two fundamental philosophies: pragmatic and theoretical. In the pragmatic 
paradigm, scientists use local data to construct pathways and to structure networks based 
on current knowledge. In Figure 2, for example, we represent the pragmatic school by the 
vertical integration of data from signaling pathways to physiological states. Exposure to 
various teratogens that give rise to a particular malformation or syndrome of 
malformations can be monitored by high-content technology platforms yielding diverse 
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data. This philosophy can be applied in top-down (phenotypes → molecules) or bottom-
up (molecules → phenotypes) mode, although in principle the genome is given the 
highest causal and informational priority over other informational levels. 
In the theoretical paradigm, priority is given to higher-level processes and 
properties of a biosystem and the genome is deprioritized. In Figure 2, for example, the 
natural system is observed by experimentalists using a traditional hypothesis-driven 
scientific method to yield information on various biological attributes at different 
information levels, e.g., molecular abundance profiles, gene-product association 
networks, metabolic and regulatory pathways, biomarkers of cellular processes and 
function, and clinical (physiological or anatomical) phenotypes. The morass of such data 
require expertise in bioinformatics, statistics, and applied mathematics to make inferences 
about the overall system properties and build models of the formal system that can lead to 
meaningful predictions of the behavior of the system under different parameters. 
In their BioEssay paper, O'Malley and Dupré (2005) raise three fundamental 
questions with regard to the basic theme of integration common to both schools of 
systems biologists: what is a system (structure); what biological units map onto a system 
(modules); and how are modular response characteristics regulated (control) and/or 
constrained by the system (logic)? A system may be defined generally as a group of 
entities comprising a whole, in which each component interacts with or is related to at 
least one other component functioning together to achieve the same objective. 
Enumerating components of the system is important for understanding of structure of the 
system, such as network topologies; however, the essence of a system resides in its 
dynamics. These dynamics must be studied in quantitative terms to construct models with 
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predictive capability. It would, however, be misleading to focus on system structure-
dynamics without paying attention to the diversity and functionality of its component 
parts. In the real world, objects may be part of the system environment but not 
necessarily required by the system to operate. Consider a light bulb inside a refrigerator 
unit: function of the light bulb may enhance the unit's environment but it is not critical for 
the unit's main function.  
2.2. Scaling, Details, and Integration 
 
Complex biological systems may be viewed from the perspective of integrated 
modules whose relationships and properties are determined by function of the system as a 
whole. The concept of modularity implies an assemblage of minimal functional units 
(subsystems) that interact with one another to give rise to emergent properties (higher 
order properties that arise from the interaction of fundamental processes in the system) of 
the system. A challenge for systems biology is to define the structure of the system and 
its modularity in terms of the inherent properties of a self-organizing system: energy, 
control, and robustness. 
Just as the discovery of the cell as the microscopic unit of life changed the way 
life itself is understood, it is logical to consider the cell as the computational unit of an 
embryo. Embryos are composed of diverse cells that are each made up of multiple 
interacting entities or parts (e.g., genes, proteins, and metabolites). Information in 
biological systems moves both up and down the scale, from molecules phenotype and 
phenotype molecules (Figure 2). Data-driven abstraction in biosystems also moves up 
and down in scale, from genes genome and metabolites metabonome. Whether based on 
high information content or high data content, the cell provides a midlevel focal plane 
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from which one can move upward or downward in scale. Because newer technologies for 
live-cell imaging enables the study of single cells in action, model-building can be 
anchored to the cell as a scale factor and the basic properties of a self-organizing system 
(energy, control, robustness) can be applied whether the scale is multicellular or 
subcellular. 
Developing embryos can be abstracted as a collection of interacting autonomous 
modules in which the behavior of each biomodule is controlled by an internal genetic 
program that can respond to local and systemic signals. We may assume that a system 
entails groups of cells that continuously interact with one another and with their local 
environment. Understanding the properties of a system at a multicellular dimension thus 
requires knowledge of biophysical constraints, such as composition of the extracellular 
milieu, the chemical nature of signal molecules that are being exchanged between cells, 
and the kinetics of chemical diffusion and receptor interaction. Similar knowledge is 
needed for modeling subcellular systems, although scaling requires consideration of 
signal transduction pathways that modulate gene expression. 
Several resources are publicly-available that utilize a universal standard exchange 
format to represent pathway-based models in general terms. To name a few: Systems 
Biology Markup Language (SBML; http://www.sbml.org) is well-suited for building 
programs to model biological processors as a wiring diagram; BioTapestry 
(http://www.biotapestry.org) meets the informational needs for computational modeling 
of developmental gene regulatory networks using the SBML workbench; CellDesigner 
(http://www.CellDesigner.org) creates process diagrams that can be linked to computer-
readable SBML files; and CytoScape (http://www.cytoscape.org) can be applied to 
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visualizing molecular interaction networks and integrating these interactions with gene 
expression profiles. These resources have broad applications for mapping connections 
between entities (genes, proteins, metabolites) in a cell to visualize how specific 
molecular mechanisms are linked with cellular physiology, and to build data-driven 
mathematical models for the analysis and prediction of druggable-targets or 
environmental-response pathways. 
2.3. Comparative bioinformatics 
 
Constructing analytical and predictive models for birth defects research is 
constrained by an incomplete understanding of the fundamental parameters underlying 
embryonic susceptibility, sensitivity, and vulnerability. To understand a developing organ 
system from a systems biology perspective, key developmental milestones must be 
parameterized in terms of system structure and dynamics, the relevant control methods, 
and the overall design logic. This is predicated on the availability of high-content data 
from studies in developmental biology and toxicology, coupled with the availability of 
bioinformatics resources to help interpret these data. 
Generally, the classification of genes that are up- and downregulated under 
specific experimental conditions or disease states using microarray-based analysis 
remains an essential part of this strategy. The availability of public resources for 
bioinformatics studies, coupled with the acquisition of contextual data from in-house 
experimentation or national data repositories, has popularized the effort to unravel 
complex biological networks using a workflow such as in Figure 3. 
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Figure 3. System-level workflow for empirical and computational definition of a 
network. 
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Newer technologies in the genomic sciences have facilitated systems biology. A 
challenge is to assign quantitative values to multiple entailments (genes, proteins, 
metabolites) under different biological states. Because these technologies are focused on 
data generation, they emphasize scale at the expense of mechanistic understanding. This 
fundamental problem requires the integration of gene expression with functional 
information. Two general classification approaches have been used for this integration: 
class enrichment and phenotypic enrichment. Class enrichment entails a non a priori 
stratification of biological themes across a list of genes ordered on the basis of expression 
difference between biological conditions. This data-driven method usually starts with 
some type of multivariate statistical method that clusters the genes in each sample by 
expression profile. An advantage is the ability to discover coarse biological themes 
without prior knowledge of the system, under the assumption that products of 
functionally related genes have similar expression profiles and hierarchical relationships. 
Phenotypic enrichment on the other hand entails an a priori assessment as to whether 
specified, predefined sets of genes are enriched in a list of genes ordered by expression 
difference between biological conditions. An advantage here, of course, is the ability to 
anchor new information with existing (prior) knowledge. In both cases, hierarchical 
clustering can find simpler developmental trajectories. Most clustering approaches do not 
account for the serial dependencies of time-course gene expression data. For that reason 
they may have difficulty determining the optimal number of trajectories that accurately 
describe time-series data. Several statistical methods have been devised to solve this 
problem. The use of these methods in conjuction with network-based analysis will allow 
for identification of cellular-response pathways in the considered dataset of fetal 
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programming of the murine mammary gland. This approach may have sufficient 
resolution to establish the hypothesis that maternal dietary fat balance during pregnancy-
lactation  has a lasting effect on mammary gland development in her daughter. 
2.4. Modeling 
2.4.1. Mathematics Pipeline 
 
Toward the goal of prioritization of chemicals for screening and regulation, the 
scientific research and regulatory policy enterprise requires a process model for 
developmental toxicity based on a reference connectivity map similar to what was 
described by Lamb et al. (2006). As mentioned earlier, part of this effort will depend on 
model-building functional networks from qualitative network topologies such as directed 
acyclic graphs (DAGs) of interactions based on expression data. Many methods of 
adapting qualitative models to learn the continuous-time character of gene regulatory 
networks have been proposed, including: discrete models that assume the network entities 
can be represented in binary state (on or off); continuous-time models with pairwise and 
weighted sum networks based on relationships between entity pairs; and Bayesian or 
belief networks that allow model-building with hidden variables and incorporate prior 
knowledge. 
Discrete models in which the precise outcomes are accurately known have been 
successful for modeling simpler genetic networks based on Boolean operators (gene is on 
or off). Gastrulation in sea urchin, for example, is built on a computational framework of 
50 or so genes affecting modules of cell fate. Boolean models generally assume only two 
possible states (expressed, not expressed) for each gene or protein in the network; this 
may be difficult to capture with typical microarray data, because discrete state transitions 
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are more likely to be conditioned on the level of gene activity, or sequence of changes 
over time, rather than whether a gene is on or off. On the other hand, methods of 
incorporating the continuous-time character of regulatory networks have been applied to 
discrete models of the segment polarity gene network in Drosophila. 
While many methods have been developed for the qualitative portrayal of gene 
product-association networks, few methods exist for quantifying the interrelated behavior 
of genes within these networks. DAGs of interactions based on limited expression data 
have been used to portray the quantitative interrelationships of genes as Bayesian 
networks. This approach has advantages to formalizing a network because it requires 
empirical gene expression data on relatively few samples, it incorporates prior knowledge 
about entities in the network, and it can address unknown (hidden) variables in the 
potential interactions. A limitation is in modeling relations among a relatively small 
number of genes, mainly due to the dimensionality problem of microarray data whereby 
the number of gene measurements far exceeds the number of samples being measured. 
This tends to restrict analytical models to represent only a small subset of the measured 
genes in the network. For example, Bayesian networks were used to model the complex 
effects of dioxin on human lung epithelial cells using empirical data collected on 12 
genes using eight samples of 27 genes to model a segment polarity gene network in 
Drosophila. Other exemplar models used 28 samples of 65 genes and 14 samples of 113 
genes. Large numbers of genes (800) are possible when the goal is to identify regulatory 
connections rather than to specify network topology. As pointed out in Huang et al. 
(2007), the poor scalability of existing techniques typically reveals only an incomplete 
structure of a gene regulatory network and these authors proposed the use of scalable 
 16 
gene regulatory network learning algorithms based on Bayesian networks and association 
rules. 
Bayesian networks can be implemented in the R package freely available from the 
R Development Core Team (2006). A Bayesian network is a DAG of nodes representing 
genes with variable attributes (expression value) and arcs representing gene-dependency 
relations. Joint distribution is represented by the variable parameters X(1), , X(n) and 
parents (A) of node A. The joint distribution for X(1) through X(n), for example, is 
represented as the product of the probability distributions for i = 1 to n. If X has no 
parents, then its probability distribution is unconditional, otherwise it is conditional. The 
extension to a stochastic process is often employed where we consider the joint 
distribution of Xt(1), , Xt(n) and where t is the time variable. Such a dynamic Bayesian 
network is appropriate for time-series microarray data. To structure the network, it is 
necessary to specify, for each node, the probability distribution of X conditional on its 
parents. Conditional distributions depend on unknown or missing parameters; therefore, 
iterative fitting techniques such as the expectation-maximization (EM) algorithm may be 
used for network optimization. A Markov Chain Monte Carlo (MCMC) algorithm can be 
applied to compute posterior distribution, giving a statistic for prediction error. Analysis 
of sensitivity-specificity employs parameters specific to each treatment group to run 
computer simulations that are conditional on actual experimental data (Figure 4). 
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Figure 4. Schema of Bayesian network (BN) and dynamic Bayesian network (DBN) 
kernels for gene network learning. 
(modeled after E. Paquet, University of Montreal, 
http://www.iro.umontreal.ca/lisa/workshop2004/slides/paquet_slides.ppt). Time-series 
(sequential) and dichotomous (nonsequential) data are run through MCMC algorithm. 
Information from the two types of data are coupled by Info tuner to construct a filtered 
DAG of nodes representing genes and arrows representing dependence relations among 
them. An optimal DAG topology is selected from sensitivity-specificity of the scoring 
criterion, such as area under the receiver-operator curve (AUROC). The network 
trajectories are then simulated for each of the vertices and the results are fed into the data 
loop for optimization. 
exemplar models used 28 samples
of 65 genes (Wahde and Hertz,
1999) and 14 samples of 113
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on its parents (Friedman et al.,
2000). Conditional distributions
depend on unknown or missing
parameters; therefore, iterative
fitting techniques such as the ex-
pectation-maximization (EM) algo-
rithm may be used for network
optimization (Hastie et al., 2001).
A Markov Chain Monte Carlo
(MCMC) algorithm can be applied
to compute posterior distribution,
giving a statistic for prediction
error (Friedman, 2004). Analysis
of sensitivity-specificity employs
parameters specific to each treat-
ment group to run computer simu-
lations that are conditional on
actual experimental data (Fig. 4).
Model refinement using ‘‘Info
tuner’’ couples the simulated results
with empirical data (Heckerman,
1999) to give significant improve-
ment in both speed and accuracy of
the learning algorithm by replacing
the greedy search with novel imple-
mentation of the Metropolis-Hast-
ings-type randomwalk (Heckerman
et al., 1995). Computational models
must be validated against empirical
data (Csete and Doyle, 2002).
Figure 4. Schema of Bayesian network (BN) and dynamic Bayesian network (DBN) kernels for gene network learning (modeled after E.
Paquet, University of Montreal, http://www.iro.umontreal.ca/~lisa/workshop2004/slides/paquet_slides.ppt). Time-series (sequential) and
dichotomous (nonsequential) data are run through MCMC algorithm. Information from the two types of data are coupled by Info tuner to
construct a filtered DAG of nodes representing genes and arrows representing dependence relations among them. An optimal DAG topol-
ogy is selected from sensitivity-specificity of the scoring criterion, such as area under the receiver-operator curve (AUROC). The network
trajectories are then simulated for each of the vertices and the results are fed into the data loop for optimization.
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Model refinement using Info tuner couples the simulated results with empirical 
data to give significant improvement in both speed and accuracy of the learning 
algorithm by replacing the greedy search with novel implementation of the Metropolis-
Hastings-type random walk. Computational models must be validated against empirical 
data. Bayesian techniques are particularly suited to treating some of the major difficulties 
associated with validation: quantifying multiple sources of error and uncertainty in 
reaction models; combining multiple sources of information; and updating validation 
assessments as new information is acquired. Several standard methods of sampling from 
the probability distribution are available based on a variety of MCMC-type schemes. 
Gamma and beta priors for the hypothesized system parameters can give posterior 
assessment of the model predictive power and assess how well the model performs. With 
that information the model deficiencies could be addressed and the initial model refined. 
2.4.2. Critical decisions of a bionetwork 
 
Given that most high-content genomics data is collected on blocks of cells or 
tissues, it is important to think about how to anchor Bayesian networks to specific 
cellular processes that operate jointly across time and in different parts of the embryo. 
Using experimental manipulations such as small interfering RNAs (RNAi), genetic 
knockouts, mutations, and drugs or chemicals, one can begin to explore the quantitative 
response to specific changes in the network entities (nodes) and relations (arcs). One 
approach is to assume that the fundamental molecular interactions have both 
deterministic and stochastic components, then simulate networks using a standard 
stochastic simulation algorithm and analyze complex behaviors in the perturbed system. 
Because disrupting gene function (e.g., knockouts, knockdowns, mutations, and altered 
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expression) can perturb embryogenesis, and because various teratogens may reprogram 
developmental networks, it is useful to begin to run different simulations on the Bayesian 
networks to predict which genes and genetic dependencies can have the greatest impact 
on the flow of molecular regulatory information through the network. Thus, once a gene 
network structure has been predicted by the bioinformatics and mathematical pipelines 
described above, a pathway can be represented as a weighted, directed graph (Young, 
Nolte et al. 2008) with a set of vertices, V, representing the genes in the case of a gene 
expression network, and a set of edges, E, representing their formal interactions. The 
network can then be portrayed with the weights representing the level of importance of 
each interaction as measured through the correlation of gene expression values, along 
with additional supporting data that may be obtained from external sources such as 
transcription factor databases, genotype-phenotype databases and so forth. Figure 5 
represents such a gene interaction network for the 14 genes (labeled 0-13) determined 
using a Bayesian network approach (see Figure 4). In this simplified example, the 
modeled relations indicate that genes 12 and 13 interact with each other, but not with any 
of the remaining genes in the network. Given a directed, weighted graph representation, a 
number of properties can be determined regarding the interactions. Using graph theory, it 
is possible to determine all possible paths beginning at one node and ending at another. In 
Figure 5A, two possible paths can link nodes 1 and 11: 123 81011 and 145910 11, based 
on current knowledge and empirical data. Since each edge is directed and weighted, the 
minimum spanning tree can be determined in more complex schema using Kruskal's 
algorithm. This returns the fewest number of interactions needed to have a functional 
path. 
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Figure 5. Computational perturbation of modeled gene product association 
networks. 
A: Network model constructed from the Bayesian effort illustrated in Figure 4, with a 
genetic dependency flow for genes 0 to 11. B: Shortest path of information flow between 
nodes 0 11 shown in red. C: Model for the removal (e.g., genetic knockout, miRNA 
knockdown) of two nodes, in this case nodes 3 and 5, leaving three disjoint gaps in the 
pathway. D: Emergence of a new connection between nodes 2 and 6 (red arrow), 
enabling a new information path from nodes 0 11 and 1 11. 
Bayesian techniques are particu-
larly suited to treating some of the
major difficulties associated with
validation: quantifying multiple
sources of error and uncertainty in
reaction models; combining multi-
ple sources of information; and
updating validation assessments as
new information is acquired (Ober-
kampf and Trucano, 2000; Bower
and Bolouri, 2001; Bayarri et al.,
2002; Rao and Arkin, 2003;
Rempala et al., 2006; Ball et al.,
2007). Several standard methods of
sampling from the probability distri-
bution are available based on a vari-
ety ofMCMC-type schemes (Tierney,
1994). Gamma and beta priors for
the hypothesized system parame-
ters can give posterior assessment
of the model predictive power and
assess howwell themodel performs.
With that information the model
deficiencies could be addressed and
the initialmodel refined.
CRITICAL DECISIONS
OF A BIONETWORK
Given that most high-content
genomics data is collected on
blocks of cells or tissues, it is
important to think about how to
anchor Bayesian networks to spe-
cific cellular processes that operate
jointly across time and in different
parts of the embryo. Using experi-
mental manipulations such as
small interfering RNAs (RNAi),
genetic knockouts, mutations, and
drugs or chemicals, one can begin
to explore the quantitative
response to specific changes in the
network entities (nodes) and rela-
tions (arcs). One approach is to
assume that the fundamental mo-
lecular interactions have both
deterministic and stochastic com-
ponents (Rao and Arkin, 2003;
Rempala et al., 2006; Ball et al.,
2007), then imulate networks
using a standard stochastic simula-
tion algorithm (Gillespie, 1977)
and analyze complex behaviors in
the perturbed system (Lu and
Ramos, 2003). Because disrupting
gene function (e.g., knockouts,
knockdowns, mutations, and
altered expression) can perturb
embryogenesis, and because vari-
ous teratogens may reprogram de-
velopmental networks (Green
et al., 2007), it is useful to begin
to run different simulations on the
Bayesian networks to predict which
genes and genetic dependencies
can have the greatest impact on
the flow of molecular regulatory in-
formation through the network.
Thus, once a gene network struc-
ture has been predicted by the bio-
informatics and mathematical
pipelines described above, a path-
way can be represented as a
weighted, directed graph {V, E}
with a set of vertices, V, represent-
ing the genes in the case of a gene
expression network, and a set of
edges, E, representing their formal
interactions. The network can then
be portrayed with the weights rep-
resenting the level of importance
of each interaction as measured
through the correlation of gene
expression values (Toyoshiba
et al., 2004), along with additional
supporting data that may be
obtained from external sources
such as EMAP, transcription factor
databases, genotype–phenotype
databases and so forth. Figure 5
represents such a gene interaction
network for the 14 genes (labeled
0–13) determined using a Bayes-
ian network approach (see Fig. 4).
In this simplified example, the
modeled relations indicate that
genes 12 and 13 interact with each
other, but not with any of the
remaining genes in the network.
Given a directed, weighted graph
representation, a number of prop-
erties can be determined regarding
the interactions. Using graph
theory, it is possible to determine
all possible paths beginning at one
node and ending at another. In Fig-
ure 5A, two possible paths can link
nodes 1 and 11: 1?2?3?
8?10?11 and 1?4?5?9?10?
11, based on current knowledge
and empirical data. Since each
edge is directed and weighted, the
minimum spanning tree can be
determined in more complex
schema using Kruskal’s algorithm.
This returns the fewest number of
interactions needed to have a
functional path.
In addition, the shortest cost
and minimum cost paths can be
calculated according to either the
number of genes involved in the
path, or the weights of the inter-
actions between the genes. Figure
5B shows a shortest path between
genes 0 and 11 in red. Each of the
individual paths in the network
potentially represents how the
flow of information might react to
physiological signals or perturba-
tions related to development. In
Figure 5. Computational perturbation of modeled gene product association networks. A: Network model constructed from the
Bayesian effort illustrated in Figure 4, with a genetic dependency flow for genes 0 to 11. B: Shortest path of information flow
between nodes 0 ? 11 shown in red. C: Model for the removal (e.g., genetic knockout, miRNA knockdown) of two nodes, in this case
nodes 3 and 5, leaving three disjoint gaps in the pathway. D: Emergence of a new connection between nodes 2 and 6 (red arrow),
enabling a new information path from nodes 0 ? 11 and 1 ? 11.
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In addition, the shortest cost and minimum cost paths can be calculated according 
to either the number of genes involved in the path, or the weights of the interactions 
between the genes. Figure 5B shows a shortest path between genes 0 and 11 in red. Each 
of the individual paths in the network potentially represents how the flow of information 
might react to physiological signals or perturbations related to development. In the case 
of fetal alcohol syndrome, for example, we may envisage qualitative network topologies 
that identify sensitive genes and their potential connections, then limit the networks to 
those interactions with the strongest weight of evidence for genetic dependencies, 
construct Bayesian models to arrange the nodes and edges in the pathway (Figure 4), and 
finally impute how a teratogen might disrupt the flow of information across the network 
to alter downstream processes. Another step in examining such a graph might be to 
determine the set of vertices (V) and edges (E) most vital to network integrity. In other 
words, which nodes, when removed, result in a disjoint set that will not allow for 
traversal from the first node in the pathway (source) to the final product (sink)? Figure 
5C shows what might happen when two critical nodes are removed, while Figure 5D 
indicates a single relation that can potentially restore the interaction network. The 
resulting effect on the network as a whole can be predicted by traversing the pathway 
from input to the output using a shortest cost path approach as with Dijkstra's algorithm, 
in which the cost of the path is inversely proportional to the weighted edge. Representing 
the pathway as an adjacency matrix of a graph as such can enable each of these steps to 
be incorporated and run in a relatively short period of time for a thorough analysis of 
individual pathways and to eventually predict outcomes computationally. 
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2.4.3. Toward a predictive understanding of developmental toxicity 
 
Multistudy expression profiles have been run across systems of the mouse embryo 
during normal development and following teratogen exposure. Although those studies 
were limited to microarray gene expression data, an integrative analysis of the mouse 
embryonic transcriptome revealed hidden relationships that might not be discovered 
without bioinformatics resources. This motivates a continuation of research efforts to 
model developmental toxicity at the level of the embryonic transcriptome. Two important 
goals are to find a minimal set of genes with adequate discriminating power to categorize 
the samples by experimental parameter, and to design a prediction system using the 
selected genes to accurately classify unknown samples. Figure 6 presents a conceptual 
framework for intelligent model selection in comparative toxicogenomics of birth defects 
and developmental disease. 
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Figure 6. Conceptual framework for intelligent model selection in comparative 
toxicogenomics of birth defects and developmental disease. 
a: The original microarray data representing the quantitative descriptions of gene 
expression levels given a specific developmental stressor. b: The original data are 
randomly divided into Training Data and Test data; each data set has similar sample 
numbers. Blue lines represent cleansed data processed through nonlinear principal 
components analysis PCA (NLPCA); black lines refer to the uncleansed data. The 
various paths these data can take are shown by the arrows, e.g.,: Bayesian variable 
selection (BVS) network analysis through Bayesian networks (BN) or neural networks 
(NN). c: The corresponding models from each path are depicted as a manifold in which 
each circle represents a DAG containing the stochastic dependencies of the genes on one 
another and on the phenotype as quantified by probability density functions. The BN 
manifold defines an order of network models having a class of networks linked to the 
different input conditions (e.g., different sets of significant genes). d: Test data used as 
input into the DAGs representing the BN models of (c). e: For an unknown sample, the 
probability of developing the phenotype of interest is represented by the diamonds and is 
calculated from the input Test data sets; this probability represents output of (d) when 
input with test data set. It allows calculation of the true negative and true positive rates by 
comparison with the actual phenotypic expression/nonexpression of the Test data set. f: 
The NN manifold defines an order of network models having a class of networks linked 
to the different input conditions; each circle is a NN model consisting of nonprobabilistic 
nodes (neurons), contrasted to the probabilistic nature of the models in (c), representing 
nonlinear regression. This establishes a nonprobabilistic mathematical relationship of 
ble jump aspect of this particular
MCMC simply allows movement
around different dimensional sub-
spaces. Furthermore, this method
can predict the class membership
of future observations. The gen-
eral approach for estimating the
parameters of interest uses Me-
tropolis moves and the RJMCMC,
as follows: 1) update parameters
from their full conditions (Gibbs
sampler); 2) split one mixture
component into two, or merge two
into one (split/merge moves); and
3) birth or death of an empty
component (birth/death moves).
The birth/death moves specifically
deal with creating/deleting empty
comp nents and do no involve
reallocation of the observations
(e.g., the entire data space does
not need to be recomputed),
hence avoiding doubling-back t
unproductive models and reaching
a faster convergence to a poste-
rior. Optimal variables are identi-
fied by selecting those with the
largest marginal posterior density.
This Bayesian variable selection
(BVS) method is complicated but
has been utilized successfully in
benchmark plant (iris) data and
DNA microarray data from endo-
metrial cancer patients (Tadesse
et al., 2005).
To compare different models for
critical gene solutions, a manifold
of Bayesian networks (BN) and of
neural networks (NN) are com-
puted from the sample data using
the paradigm suggested in Figure
7. The BN approach is described
above; within the field of NN, there
are a variety of network architec-
tures built in MATLAB NN toolbox
Figure 7. Conceptual framework for intelligent model selection in comparative toxicogenomics of birth defects and developmental
disease. a: The original microarray data representing the quantitative descriptions of gene expression levels given a specific develop-
mental stressor. b: The original data are randomly divided into Training Data and Test data; each data set has similar sample numbers.
Blue lines represent cleansed data processed through nonlinear principal components analysis PCA (NLPCA); black lines refer to the
uncleansed data. The various paths these data can take are shown by the arrows, e.g.,: Bayesian variable selection (BVS) ? network
analysis through Bayesian networks (BN) or neural networks (NN). c: The corresponding models from each path are depicted as a
manifold in which each ‘‘circle’’ represents a DAG containing the stochastic dependencies of the genes on one another and on the phe-
notype as quantified by pr bability dens ty functions. The BN manifold d fines an ‘‘order’’ of network models having ‘‘class’’ of net-
works linked to the different input conditions (e.g., different sets of significant genes). d: Test data used as input into the DAGs repre-
senting the BN models of (c). e: For an unknown sample, the probability of developing the phenotype of interest is represented by the
diamonds and is calculated from the input Test data sets; this prob bility represents output of (d) when input with test data set. It
allows calculation of the ‘‘true negative’’ and ‘‘true positive’’ rates by comparison with the actual phenotypic expression/nonexpression
of the Test data set. f: The NN manifold defines an ‘‘order’’ of network models having a ‘‘class’’ of networks linked to the different input
conditions; each circle is a NN model consisting of onprob bilistic nodes (neurons), contrasted to the probabilistic nature of the mod-
els in (c), representing nonlinear regression. This establishes a nonprobabilistic mathematical relationship of gene interdependencies
and gene dependency on the phenotype. g: Test data set used as input into the NN models of (f). h: Prediction of phenotypic expres-
sion or nonexpression based on input Test data set: allows calculation of the true negative and true positive rates by comparison with
the actual phenotypic expression/nonexpression of the Test data set. AIC and BIC: because multiple data sets may be run for each
order of network models, there will be many model classes to compare. Each class of models can be compared within order (e.g., BN-
BN, NN-NN) as well as between order (e.g., BN-NN, NN-BN) and the consensus ‘‘species’’ of network models will be used for further
validation. Akaike information criterion (AIC) and Bayesian information criterion (BIC) assist in selection of the optimal species by
essentially scoring the parsimony of the data and finding the opti al number of variables weighed against the model’s error.
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gene interdependencies and gene dependency on the phenotype. g: Test data set used as 
input into the NN models of (f). h: Prediction of phenotypic expression or nonexpression 
based on input Test data set: allows calculation of the true negative and true positive rates 
by comparison with the actual phenotypic expression/nonexpression of the Test data set. 
AIC and BIC: because multiple data sets may be run for each order of network models, 
there will be many model classes to compare. Each class of models can be compared 
within order (e.g., BN-BN, NN-NN) as well as between order (e.g., BN-NN, NN-BN) 
and the consensus species of network models will be used for further validation. Akaike 
information criterion (AIC) and Bayesian information criterion (BIC) assist in selection 
of the optimal species by essentially scoring the parsimony of the data and finding the 
optimal number of variables weighed against the model's error. 
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Predictive modeling in developmental toxicology starting from microarray gene 
expression data will require a series of steps, from denoising algorithms to optimal 
variable selection and model comparison. The starting data are assumed to have inherent 
structure that is related to the biological condition of the test samples and that is 
expressed by many variables (e.g., high-dimensional), some having significance to the 
phenotype and others not contributing significantly. Many analysis methods of 
unsupervised clustering have been described to find the more compact description of the 
data (e.g., low-dimensional) and will not be described here. The problem here, however, 
is to define an underlying structure in the regulation of the embryonic transcriptome 
where the standard learning task identifies gene networks significantly anchored to the 
risk of developmental phenotypes. 
Nonlinear principal component analysis (NLPCA) is powerful method of data 
cleansing that is conceptually a nonlinear extension of the popular principal components 
analysis (PCA), which finds the directions of greatest variance in the data set and 
represents each data point by its Cartesian coordinates along each axis. The nonlinear 
generalization of PCA has been described to transform high-dimensional data into a low 
dimensional code (encoder network) and to recover the structured data (decoder network) 
under the constraint that initial weights of the data should be close to a solution. NLPCA 
is accomplished using an autoassociative neural network, which is a neural network that 
has exactly as many output neurons as input neurons, and is trained (an optimization 
routine) so that its outputs match its inputs for all data presented. The concept in Figure 6 
contains a modified feed-forward multilayer layer perceptron neural network, whereby 
input and output layers have linear activation functions to allow recovery of the input 
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space; three hidden layers with nonlinear activation functions (sigmoid, tansigmoid, etc.) 
give the network nonlinear mapping capability. The middle hidden layer functions as a 
bottleneck because it contains fewer neurons than the two other hidden layers or input 
and output layers. This limits the autoassociation and thus removes information that does 
not contribute to the feature space (e.g., risk for a particular phenotype). Such networks 
are very useful in cleansing the data because the network can, knowing what gene 
interaction signatures look like, separate the gene pathway data from statistically 
insignificant information in a nonlinear way. The output of NLPCA is cleansed or 
denoised data, which is then used as input into optimal variable selection techniques 
based on Bayesian principles. 
Optimal variable selection using the Bayesian paradigm is another powerful tool 
to lower dimensionality to focus on entities (variables) that are significant contributors to 
the group structure of the data. Two inherent assumptions are as follows: 1) that an 
optimal subset of genes can be found (solution) that can account for a particular 
phenotype, such as fetal alcohol syndrome; and 2) that most genes do not contribute 
significantly to the syndrome. The validity of these assumptions must be confirmed 
although they appear to be reasonable given microarray data for experimental fetal 
alcohol syndrome in mice. (Tadesse, Sha et al. 2005) developed a data-driven method 
that selects discriminating variables into G groups, where G is unknown. This clustering 
approach is a multivariate mixture model with an unknown number of components and 
uses a binary latent vector that effectively searches through all subsets using the 
Reversible Jump Markov Chain Monte Carlo (RJMCMC) algorithm. The reversible jump 
aspect of this particular MCMC simply allows movement around different dimensional 
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subspaces. Furthermore, this method can predict the class membership of future 
observations. The general approach for estimating the parameters of interest uses 
Metropolis moves and the RJMCMC, as follows: 1) update parameters from their full 
conditions (Gibbs sampler); 2) split one mixture component into two, or merge two into 
one (split/merge moves); and 3) birth or death of an empty component (birth/death 
moves). The birth/death moves specifically deal with creating/deleting empty 
components and do not involve reallocation of the observations (e.g., the entire data 
space does not need to be recomputed), hence avoiding doubling-back to unproductive 
models and reaching a faster convergence to a posterior. Optimal variables are identified 
by selecting those with the largest marginal posterior density. This Bayesian variable 
selection (BVS) method is complicated but has been utilized successfully in benchmark 
plant (iris) data and DNA microarray data from endometrial cancer patients (Tadesse, 
Sha et al. 2005). 
To compare different models for critical gene solutions, a manifold of Bayesian 
networks (BN) and of neural networks (NN) are computed from the sample data using the 
paradigm suggested in Figure 6. The BN approach is described above; within the field of 
NN, there are a variety of network architectures built in MATLAB NN toolbox software 
that include feed-forward multilayer perceptron networks (The Mathworks, Inc., Natick, 
MA). An optimal network of genes associated with a particular risk for malformation, 
defined as a species, might be theorized at the convergence of different class models onto 
a minimal set of entities (genes) having maximized interactions (relations). In this case, a 
tradeoff of complexity in a model versus how well a model fits the data can be assessed 
using the Akaike information criterion (AIC) and Bayesian information criterion (BIC) 
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that reward goodness of fit and penalize parameters. These statistical methods are rooted 
in information theory and are indicative of the parsimony of the final model, where a 
decrease in value corresponds to an improved model. 
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3. METHODS 
 
3.1. Experimental (animal) studies at RIVM, the Netherlands 
 
 Wild type FVB/NHanHsd mice, six to eight-weeks old, were obtained from 
Harlan (Horst, NL). All mice were housed in the animal facility in a climate-controlled 
room with a 12 h on/off light cycle. Tap water and diets as described below were 
provided ad libitum. Animals were monitored daily for general health. The animal 
protocol used in this research was reviewed and approved by the Institutional Animal 
Care and Use Committee (IACUC) at the University of Louisville. The research was also 
approved by the Animal Ethics Committee (IACUC) of the Dutch National Vaccine 
Institute (NVI) at Bilthoven, which also serves as the IACUC of the National Institute for 
Public Health and the Environment (RIVM) where the animal work was performed for 
this study. 
 All diets used in this experiment were obtained from AB Diets (Woerden, NL). 
Mice in the control group were fed a low-fat (5%) regular diet. The high-fat diets 
contained 24% fat at the expense of carbohydrates and were based on corn oil (high ratio 
of n-6/n-3 PUFAs) or flaxseed oil (low ratio of n-6/n-3 PUFAs) (Chempri 
Oleochemicals, Raamsdonksveer, NL).  
 The study presented here consisted of two dietary exposure groups and one 
control group, with differing proportions of polyunsaturated fatty acids (PUFAs). Each 
dietary group consisted of 6 females and 3 males. After one week of acclimation to the 
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animal room and two weeks prior to mating the dams and sires were shifted from 
standard mouse chow to one of the treatment diets. Females were allowed to breed during 
one week with the males. Subsequently, dams were housed individually and maintained 
on their respective diets through birth and until weaning of their litters. The number of 
pups born alive was recorded at the day of parturition, designated postnatal day (PND) 0. 
Body weights of all pups were recorded on PND 1, PND 7, and PND 14. After weaning 
on PND 21, male pups were euthanized by carbon dioxide asphyxiation. F1 female pups 
were kept on the appropriate treatment diets until 6 weeks of age. At 6 weeks the F1 
female mice were shifted to the standard low-fat (5%) chow until terminal sacrifice at 10 
weeks of age. Body weights of F1 female pups (n = 21 for the control group, n = 12 for 
the high-fat corn oil group, and n = 15 for the high-fat flaxseed oil group) were recorded 
weekly from PND 21 until 10 weeks of age. At autopsy, blood and major organs were 
isolated from each animal, including the fourth abdominal mammary gland on the right 
side of the mouse, liver, kidney and spleen. The mammary gland was kept in RNAlater 
RNA stabilization Solution (Ambion, Austin, Texas) at 4 °C for maximally 14 days; 
other organs were snap frozen in liquid nitrogen. A schematic overview of the study 
design is depicted in Figure 7. 
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Figure 7. Study design 
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3.2. RNA isolation and microarray analysis 
 
 DNA/RNA was extracted by using AllPrep DNA/RNA mini isolation kit (Qiagen, 
Valencia, CA, USA). RNA samples were treated with the RNase-Free DNase set 
(Qiagen) and concentrations were measured using a NanoDrop Spectrophotometer 
(NanoDrop Technologies, Wilmington, DE, USA). RNA was assessed for quality with 
the Bioanalyzer 2100 (Agilent Technologies, Palo Alto, CA, USA). Both the RNA 
integrity number and the presence of degradation products were checked. 
The mouse oligonucleotide libraries (catalog no. MOULIBST and 
MOULIB384B) were obtained from Sigma-Compugen, Inc. Technical support was 
supplied by LabOnWeb (http://www.labonweb.com/cgi-bin/chips/full_loader.cgi). The 
libraries represent in total 21,766 LEADS™ clusters plus 231 controls. The 
oligonucelotide library was printed with a Lucidea Spotter (Amersham Pharmacia 
Biosciences, Piscataway, NJ, USA) on commercial UltraGAPS slides (amino-silane-
coated slides, Corning 40017) and processed according to the manufacturer's instructions. 
The slides contained 65-mer oligonucleotides, and the batch was checked for the quality 
of spotting by hybridizing with SpotCheck Cy3-labeled nonamers (Genetix, New Milton, 
Hampshire, UK).  
 Total RNA samples were hybridized in randomized batches, according to a 
common reference design without dye swap. An RNA pool of all samples isolated was 
used as a common reference. From the total RNA samples with an RNA integrity number 
value of >7, 1.0 µg was amplified using the Amino Allyl MessageAmp amplified RNA 
kit (Ambion) and labeled with Cy5 (experimental samples) and Cy3 (common reference) 
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reactive dye according to the manufacturer's instructions. The microarrays were 
hybridized overnight with 200 µl hybridization mixture, consisting of 50 µl Cy3- and 
Cy5-labeled amplified RNA (with 150 pmol Cy3 and 150 pmol Cy5), 100 µl formamide, 
and 50 µl 4× RPK0325 microarray hybridization buffer (Amersham Pharmacia 
Biosciences), at 37°C, washed in an automated slide processor (Amersham Pharmacia 
Biosciences), and subsequently scanned at two wavelengths using a ScanArray 4000XL 
microarray scanner (Perkin-Elmer, Waltham, MA, USA). Median Cy3 and Cy5 signal 
intensities per spot were determined using Array Vision software (Imaging Research, St. 
Catharines, Ontario, Canada).   
 In total, 28 two-color mouse genome (M. musculus) cDNA microarrays were used 
in this study, representing 4 batch groups: Groups A and B (n =6 each) were from the 5% 
fat diet (control) groups, and Groups C and D (n =8 each) were from the treatment 
groups. The microarray processing was done on 4 different dates, and all groups were 
processed on each of these days; therefore, treatment is not nested within batch. For 
purposes of the analysis, the two control groups were combined (n =12).  
3.3. Pre-processing of microarray dataset 
 
 Microarray quality control was performed on raw data by means of visual 
inspection of the scanned images, as well as a check on the scatter and MA plots. Image 
plots, box plots, MVA plots, and histograms were used to assess data and microarray 
processing quality. The image plots show that several arrays had large areas with cold 
spots during some of the runs. One of the arrays (A3) had close to 30% of its area taken 
up by cold spots. There is a potential that these spots had an adverse affect upon the 
analysis. Normalization methods cannot be relied upon to eliminate the effect of large 
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cold spots. The BioConductor software packages arrayQuality and marray were used to 
assess array quality. An offset of 50 was used for background correction to avoid 
negative or zero corrected intensities and to preserve variance for analysis of differential 
expression. Locally weighted regression was used to normalize within arrays. Finally, 
quantile normalization was performed across arrays because of the large variation 
between arrays seen in the box plots (Figure 8).  
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Figure 8. Boxplots before and after normalization 
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3.4. Microarray data analysis 
 
 Several data analysis models were used to identify genes that were differentially 
expressed between the treatment groups and the control group.  
3.4.1. Method 1 – analysis of variance, hierarchical clustering 
 
 In the first model, two-way analysis of variance (ANOVA) was employed that 
takes into account the batch effect (date of microarray processing) as well as the 
treatment effect. Treatment effect was included last in the model to account for the 
unbalanced design. To correct for multiple testing, Benjamini-Hochberg’s false discovery 
rate (FDR) (Benjamini and Hochberg 1995) was used with a cut-off of 0.05. The F1 
statistics were used for gene set enrichment analysis (GSEA) (Mootha, Lindgren et al. 
2003). All pathways present in the c4 database of the Molecular Signatures Database 
(MSigDB 2.0; http://www.broad.mit.edu/gsea/msigdb/msigdb_index.html) were tested 
for significance. 
 Hierarchical clustering was employed using Euclidian distance as a dissimilarity 
measure. In addition, the DAVID ‘Functional Annotation Clustering’ tool (Dennis, 
Sherman et al. 2003) was used to cluster the 99 genes into different groups (more than 
15). The method allows genes to belong to more than one group.  
3.4.2. Method 2 – principle component analysis, analysis of variance 
  
 In the second model, ratiometric values (test/reference) were transformed to log2 
and normalized with Lowess smoothing. Batch and litter-size effects were removed using 
Partek Genomics Suite v 6.3 (Partek Inc.; www.partek.com) and the residual variance 
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was analyzed by Principal Components Analysis (PCA), one-way ANOVA (P ≤ 0.005) 
and specific group comparisons. All data was mean-centered and quantile normalized to 
make the gene expression distributions across the different microarrays similar. This 
analysis returned 670 genes for subsequent cluster analysis and functional annotation.  
3.4.3. Method 3 – Bayesian variable selection  
 
 In the third model, a Bayesian-based variable selection (BVS) algorithm was 
applied. A systematic methodology for identifying optimal discriminative gene subsets in 
the analysis of this data (controls and flax) is adopted via a Bayesian-based variable 
selection algorithm (BVS) utilizing the stochastic search technique. BVS analysis was 
implemented in MATLAB (The MathWorks, Inc. 3 Applehill Drive, Natick, MA 01760-
2098) using code available from Marina Vannucci (Bayesian variable selection in 
multinomial probit models 2004 - http://www.stat.rice.edu/~marina/codes.html) (Sha, 
Vannucci et al. 2004), additional coding written in MATLAB. The MATLAB 
Bioinformatics Toolbox 2.5 was utilized in generating heatmaps and gene ontology 
enrichment.  
Vannucci (P. J. Brown 1998) implemented a BVS methodology that builds upon 
the stochastic search variable selection technique (SSVS). The idea of SSVS is to embed 
a linear regression model into a hierarchical Bayes model, where regression coefficients 
are given mixture priors. Vannucci’s code extended the model to the general multivariate 
case for probits and multinomial classification (Sha, Vannucci et al. 2004). This is 
accomplished through the use of latent (unobserved) variables representing the 
categorical response. Introduction of latent data (data augmentation) into the model 
allows the probit model to be transformed into a linear regression problem in the 
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multivariate normal context. Essentially, the entire regression model is embedded into a 
hierarchical Bayes normal mixture model, where latent variables are used for subset 
selection. A key idea for variable selection in this context is introduction of a binary p-
vector γ that indexes all possible variable subsets. More specifically, the jth element of 
the latent binary p-vector γ ,γj , is 0 or 1, corresponds to inclusion or exclusion of a 
particular variable in the gene subset. This vector takes 2p values. Elaborating on the 
priors of the regression coefficients by assuming the coefficients come from a normal 
mixture facilitates assessment of the importance of a variable in the model. The prior 
distributions of γj’s are set as independent Bernoulli (collectively Binomial). 
Through appropriate prior elicitation and integration of parameters out of the joint 
posterior, the posterior distribution of all possible subsets given the data can be derived 
but is of unknown form. This posterior space is searched via Metropolis-Hastings using 
add/delete/swap Metropolis moves. More specifically, a fast-inference scheme is adopted 
by deriving the marginal posterior distribution of the latent vector γ given the data by 
integrating out other parameters from the joint posterior distribution (Sha, Vannucci et al. 
2004). Again, the distribution of γ is not of known form and is explored using Markov 
Chain Monte Carlo (MCMC), where the Markov Chain is constructed using the 
Metropolis-Hastings algorithm. The composition of the variable subset (i.e. genes) 
evolves as we iterate through in the MCMC context by searching the 2p space using 
add/delete/swap Metropolis moves (add/delete: randomly choose one of the p indices in 
γold and change its value from 0 to 1 (add), or from 1 to 0 (delete), to become γnew;  swap: 
independently choose and at random a 0 and a 1 in γold, switch their values to get γnew). 
Subsets and variables with a higher joint posterior probability can be identified by more 
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frequent occurrence in the MCMC output. As a result, posterior inference of γ, and thus 
the composition of the variable subsets, is completely data-based after hyperparameter 
specification. Prediction performance of these gene subsets is assessed using a sampling-
based cross-validation prediction procedure due to the small number of microarrays in 
relation to the large number of variables.  
A key attractive feature of this technique is that it assesses the joint effects of the 
variables. Two variables independently may not be descriptive given the observed data, 
but in conjunction, are valuable predictors. Because variable subsets are selected on the 
basis of maximal joint posterior density, the subsets will inherently attempt to avoid 
correlation of included variables, as inclusion of an additional highly-correlated variable 
(at the expense of a potentially valuable predictor) into a model brings no additional 
predictive power, leading to no increase in joint posterior probability. Data for this 
technique must be pre-processed by mean-centering and rescaling by variable range. 
Advantages of this implementation are that the subset selections assess the joint effect of 
variables in attempting to account for the discriminative changes seen in the response 
data and that this procedure truly determines how “valuable” a variable is. Disadvantages 
are computational demands due to the vast and highly complex posterior space (defined 
on all possible subsets, 2p), where it may not be possible to efficient search over the space 
in extremely large datasets. Also, there is risk that the MCMC procedure does not 
converge to the posterior distribution within a reasonable timeframe. This can be 
minimized by running multiple chains for long periods, discarding all but the last 
iterations, and pooling the MCMC. Prior specification is also an issue, although the 
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authors give procedures for calibration of the priors from the data and from theoretical 
constraints (avoiding Lindley’s Paradox). The SSVS schema is shown in Figure 9. 
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Figure 9. Layout of stochastic search variable selection technique 
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Hyperparameters controlling model shrinkage, prior probabilities of variable 
inclusion, and model expectation size were all specified. The parameter related to total 
relative prior to posterior precision was taken as the average of the values corresponding 
to 0.1 and 0.005. This specific hyperparameter regulates the amount of shrinkage in the 
model and is related to the ridge regression. Prior probabilities of variable inclusion are 
assigned independent Bernoulli trials where p is assigned ½. Because it is expected and 
desired to have few genes in the gene subset, the binomial prior for the chosen variables 
(genes) in γ is set to have an expectation of 10, so that the MCMC procedure tends 
toward the space of smaller models. MCMC was run for 500,000 iterations, where the 
first 100,000 were discarded as burn-in. The starting γ vector was taken with 10 randomly 
selected genes included. 
Vannucci et al. have extended variable selection to incorporation in clustering high-
dimensional data. Future work may be done to explore the cluster structure and 
associated significant variables (Sinae, Mahlet et al. 2006) (Tadesse, Sha et al. 2005). 
3.5. Fatty acid profiling of exposure diets and mouse sera (RIVM) 
 
Fatty acid composition was analyzed both in the various animal diets and in a 
representative number of sera obtained from mice fed these diets. Methods were adapted 
from procedures described earlier (Mamalakis, Jansen et al. 2006). Fatty acids have been 
expressed as percent of the total fatty acids present in the chromatogram. 
3.6. Statistical analyses 
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General statistical procedures were performed with either SPSS version 12.0.1 or 
S-PLUS 2000 statistical software packages. All values were expressed as means ± 
standard deviations when appropriate. Reproductive parameters and pup weights of PND 
1 were analyzed using one-way ANOVA. Body weights of female pups from 3 to 10 
weeks of age were analyzed using a nonlinear mixed effects model. The nonlinearity is 
formed by an asymptotic 
growth model, in which the weight yij of mouse i at time tj is modeled as: 
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4. Results 
4.1. Phenotype anchors (RIVM) 
 
 Maternal dietary exposure to a high-fat diet, rich in either n-6 or n-3 PUFAs, did 
not result in significant effects on pregnancy rate, litter size or sex ratio (data not shown). 
The number of female pups born in each dietary group was n = 21 for the control group, 
n = 12 for the high-fat corn oil group, and n = 15 for the high-fat flaxseed oil group. 
4.2. Fatty acid profiling  
 
 To investigate whether perinatal exposure to treatment diets high in n-6 or n-3 
PUFAs was still detectable at time of sacrifice (i.e. 4 weeks after cessation of treatment), 
fatty acid profiling of a representative number of mouse sera was performed. The n-6/n-3 
PUFA ratio is about threefold higher in mice fed a diet based on corn oil as compared 
with mice fed a diet based on flaxseed oil. These results indicate that perinatal exposure 
to high-fat diets with either high or low n-6/n-3 PUFA ratios has a lasting effect on the 
fatty acid profile of the serum.  
4.3. Postnatal body weight gain (RIVM) 
 
Postnatal body weight trajectories are shown in Figure 10. At PND1, no statistically 
significant difference in body weight of the pups between any of the groups was 
observed. However, at 3 weeks of age, female pups from the high-fat diet groups, based 
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on either corn or flaxseed oil, were significantly heavier than female pups from the low-
fat diet (P < 0.001). In addition, body weights of F1 female pups from the high-fat diet 
groups increased more rapidly than from the control group (P < 0.001). At 10 weeks of 
age, body weights of the F1 female pups perinatally fed a high-fat diet based on corn oil 
were no longer significantly different from the control group. In contrast, female pups 
perinatally fed a high-fat diet based on flaxseed oil were still heavier than pups from the 
control group (P < 0.001), despite the fact that they were shifted to a low-fat diet from 6 
weeks of age onwards. Postnatal body weight trajectories of F1 females sustained on the 
high-fat diet based on flaxseed oil paralleled the normal growth curve, but these test 
animals remained heavier by a constant scalar. In contrast, the growth curve of females 
sustained on the high-fat diet based on corn oil approached the regular trajectory. The 
slight dip in trajectories at 3 weeks of age is accounted for by the removal of male pups, 
which are slightly heavier than females. 
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Figure 10. Developmental programming of growth trajectories in female FVBn mice 
Test diets were given maternally, from preconception through lactation (3-weeks), and 
after weaning to early juvenile life (6-weeks of age). The increased weights of high-fat 
diets were significant versus regular diet at 3-weeks and beyond; however, females from 
the fatty corn oil diet shifted to the regular trajectory between 6- and 10-weeks of age. 
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4.4. Mammary gland gene expression 
 
 Gene expression profiling of the 4th right abdominal mammary gland was 
determined on postnatal week 10. We used two different data analysis models. In the first 
model, statistical analysis using a two-way ANOVA and false discovery rate cut-off at 
P=0.05 returned 99 differentially expressed genes across the dietary groups. Pathway 
inference performed using the R package GSA (Gene Set Analysis) focused on a gene set 
from Molecular Signature Databases (MSigDB) defined by expression neighborhoods 
centered on 380 human cancer-associated genes, of which there were 28 gene sets with 
fdr less than or equal to 0.10. Functional annotation chart from DAVID showed weak 
representation of only one KEGG pathway at that same level (natural killer cell mediated 
cytotoxicity).  
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Figure 11. Heatmap of 99 differentially expressed genes 
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Figure 12. DAVID results showing one KEGG pathway (using significant genes as 
input) 
Note: one limitation of the pathway analysis performed using GSA is that the gene set 
from the Broad Institute contains genes from the human genome, and the microarray 
experiment contains genes from the mouse genome. The genes from the KEGG pathways 
contain gene symbols from both human and animal. In this analysis, all gene symbols 
were converted to upper-case, so that the analysis was across species. 
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 In the second statistical model, one-way ANOVA identified 670 genes that 
accurately classified samples by maternal diet exposure and PCA showed clear evidence 
of clustering by diet group (Figure 13B). Class differences were greatest between regular 
(5% fat) diet and high-fat (24%) based on flaxseed oil groups, with the corn oil group 
being intermediate in its response. This pattern was similar to that observed for body 
growth curves (Figure 10). Differential transcript abundance profiles could be partitioned 
neatly into two clusters of genes (Figure 13C). One cluster had 240 genes with downward 
programming by flaxseed oil. Gene Ontology (GO) scores enriched this cluster for 
biological themes to metabolism pathways: oxidative phosphorylation, TCA cycle, fatty 
acid metabolism, glyocolysis/gluconeogenesis, propanoate metabolism, and pyruvate 
metabolism. The other cluster had 430 genes with upward programming by flaxseed oil. 
GO scores enriched this cluster for morphoregulatory pathways: cell adhesion molecules 
and cytokine pathways. We may conclude from these results that maternal dietary fat 
exposure significantly influenced metabolic programming, and signaling networks in the 
mammary gland of female offspring.  
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Figure 13. Developmental programming of gene expression in the mammary gland 
Test diets (Figure 1) given to 6-weeks of age, and regular diet thereafter. Microarray 
analysis performed at 10-weeks of age; sources of variation identified for litter-size, 
treatment, and batch. After removing litter / batch effects the source of variance was 
plotted for regular diet (blue, red; n=12), fatty-diet corn oil (green, n=8) and fatty-diet 
flaxseed oil (magenta, n=8) using PCA. The heat-map shows clustering of 670 
differentially-regulated genes (horizontal) and samples (vertical)  
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4.5. Discriminatory genes identified through BVS 
 
Because PCA is a popular dimension-reduction tool in statistical models but as a 
compression technique basically categorizes data by variance, using a linear 
transformation to shift coordinate systems and compute values in the rotated coordinate 
system. By doing so, PCA decorrelates the inputs and makes them orthogonal; however, 
this linear decomposition is not inimical to gene interactions that are highly nonlinear and 
correlated. Also, PCA does not assess the joint effect of multiple variables and does not 
allow for evaluation of the original variables. Singular value composition, a very closely 
related concept (from which PCA can be derived), has also been applied to gene 
expression data to reduce dimensionality, but again, with the same problems. 
Because the BVS algorithm does not scale well above ~1000 variables and has 
not been rigorously tested above this threshold, BVS was run on an ANOVA (P < 
0.0055) gene set comprising 914 genes. The algorithm was run using the control 
(isocaloric) and flaxseed groups only. This was done because the algorithm performs 
optimally under binary classification, although the method has been extended to the 
multinomial setting. Because of the restriction to the binary classification setting, the two 
groups were chosen by those with largest group weight divergence (isolcaloric vs. 
flaxseed).  Distinct visited gene models (subsets) were sorted according to normalized 
joint posterior probability. Interesting gene subsets were chosen as the union of the top 10 
models via normalized joint posterior probability. Gene subsets can also be selected via 
top marginal density. In fact, optimal gene selection via both joint posterior density and 
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marginal density resulted in very similar gene sets. The union of the top 10 models via 
joint posterior density resulted in a 17 gene subset (Table 1).  
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Table 1. Nomenclature of the 17 gene subset (Bult CJ 2008) 
Input 
MGI 
Gene/Marker 
ID Symbol Name 
Marker 
Type 
M33425 MGI:96628 Jak1 Janus kinase 1 Gene 
NM_025543 MGI:1913655 Mcts2 
malignant T cell 
amplified sequence 2 Gene 
AB008179 MGI:1298369 Pcdha7 protocadherin alpha 7 Gene 
NM_011073 MGI:97551 Prf1 
perforin 1 (pore 
forming protein) Gene 
NM_008404 MGI:96611 Itgb2 integrin beta 2 Gene 
AF188504 MGI:2447166 Cmtm7 
CKLF-like 
MARVEL 
transmembrane 
domain containing 7 Gene 
NM_008615 MGI:97043 Me1 
malic enzyme 1, 
NADP(+)-dependent, 
cytosolic Gene 
AF294811 MGI:87961 Agrn agrin Gene 
NM_007378 MGI:109424 Abca4 
ATP-binding 
cassette, sub-family 
A (ABC1), member 4 Gene 
BC008156 MGI:2444541 Usp43 
ubiquitin specific 
peptidase 43 Gene 
AF154337 MGI:3710533 Gpr137b-ps 
G protein-coupled 
receptor 137B, 
pseudogene Gene 
NM_011116 MGI:1333782 Pld3 
phospholipase D 
family, member 3 Gene 
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AF317838 MGI:1931123 Inpp4a 
inositol 
polyphosphate-4-
phosphatase, type I Gene 
NM_010877 MGI:97284 Ncf2 
neutrophil cytosolic 
factor 2 Gene 
NM_007377 MGI:1197518 Aatk 
apoptosis-associated 
tyrosine kinase Gene 
NM_007781 MGI:1339760 Csf2rb2 
colony stimulating 
factor 2 receptor, beta 
2, low-affinity 
(granulocyte-
macrophage) Gene 
NM_011581 MGI:98738 Thbs2 thrombospondin 2 Gene 
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Figure 14. Heatmap of 17 genes from Bayesian variable selection, representing the 
union of the top 10 models via top posterior density 
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Table 2. List of genes in the 17 gene subset upregulated and their respective 
functions (per GeneGo) (Bult CJ 2008) 
MGI 
Gene 
Symbol Gene Name Goid Code 
MGI:96628 Jak1 Janus kinase 1 GO:0019221 
cytokine and chemokine 
mediated signaling 
pathway 
   GO:0007167 
enzyme linked receptor 
protein signaling 
pathway 
   GO:0018108 
peptidyl-tyrosine 
phosphorylation 
   GO:0007243 protein kinase cascade 
   GO:0004713 
protein tyrosine kinase 
activity 
   GO:0005524 ATP binding 
   GO:0005856 cytoskeleton 
   GO:0004718 Janus kinase activity 
   GO:0016301 kinase activity 
   GO:0016020 membrane 
   GO:0004715 
non-membrane spanning 
protein tyrosine kinase 
activity 
   GO:0000166 nucleotide binding 
   GO:0006468 
protein amino acid 
phosphorylation 
   GO:0004672 protein kinase activity 
   GO:0016740 transferase activity 
   GO:0005515 protein binding 
MGI:97551 Prf1 
perforin 1 (pore 
forming 
protein) GO:0019835 cytolysis 
   GO:0016023 
cytoplasmic membrane-
bounded vesicle 
   GO:0005509 calcium ion binding 
   GO:0016021 integral to membrane 
   GO:0016020 membrane 
   GO:0005615 extracellular space 
MGI:96611 Itgb2 integrin beta 2 GO:0009986 cell surface 
   GO:0007229 
integrin-mediated 
signaling pathway 
   GO:0005624 membrane fraction 
   GO:0045121 membrane raft 
 58 
   GO:0005488 binding 
   GO:0007160 cell-matrix adhesion 
   GO:0008305 integrin complex 
   GO:0016020 membrane 
   GO:0005515 protein binding 
   GO:0004872 receptor activity 
   GO:0050798 
activated T cell 
proliferation 
   GO:0007155 cell adhesion 
   GO:0045123 cellular extravasation 
   GO:0030593 neutrophil chemotaxis 
   GO:0016021 integral to membrane 
MGI:2447166 Cmtm7 
CKLF-like 
MARVEL 
transmembrane 
domain 
containing 7 GO:0006935 chemotaxis 
   GO:0005125 cytokine activity 
   GO:0005615 extracellular space 
   GO:0016020 membrane 
   GO:0016021 integral to membrane 
MGI:3710533 
Gpr137b-
ps G protein-coupled receptor 137B, pseudogene 
MGI:1333782 Pld3 
phospholipase 
D family, 
member 3 GO:0003824 catalytic activity 
   GO:0005783 endoplasmic reticulum 
   GO:0016787 hydrolase activity 
   GO:0016042 lipid catabolic process 
   GO:0016020 membrane 
   GO:0008152 metabolic process 
   GO:0005624 membrane fraction 
   GO:0004630 phospholipase D activity 
   GO:0016021 integral to membrane 
MGI:97284 Ncf2 
neutrophil 
cytosolic factor 
2 GO:0001669 acrosome 
   GO:0005737 cytoplasm 
   GO:0005488 binding 
   GO:0005829 cytosol 
   GO:0006742 NADP catabolic process 
   GO:0006801 
superoxide metabolic 
process 
   GO:0016175 superoxide-generating 
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NADPH oxidase activity 
MGI:1339760 Csf2rb2 
colony 
stimulating 
factor 2 
receptor, beta 2, 
low-affinity 
(granulocyte-
macrophage) GO:0019221 
cytokine and chemokine 
mediated signaling 
pathway 
   GO:0004896 
hematopoietin/interferon-
class (D200-domain) 
cytokine receptor activity 
   GO:0004907 
interleukin receptor 
activity 
   GO:0016020 membrane 
   GO:0004872 receptor activity 
   GO:0016021 integral to membrane 
MGI:98738 Thbs2 
thrombospondin 
2 GO:0005509 calcium ion binding 
   GO:0007155 cell adhesion 
   GO:0005576 extracellular region 
   GO:0008201 heparin binding 
   GO:0005515 protein binding 
   GO:0005198 
structural molecule 
activity 
   GO:0005615 extracellular space 
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Table 3. List of genes in the 17 gene subset downregulated and their respective 
functions (per GeneGo) (Bult CJ 2008) 
MGI 
Gene 
Symbol Gene Name Goid Code 
MGI:1913655 Mcts2 
malignant T 
cell amplified 
sequence 2 GO:0005737 cytoplasm 
   GO:0006355 
regulation of 
transcription, DNA-
dependent 
   GO:0006350 transcription 
   GO:0003723 RNA binding 
MGI:109424 Abca4 
ATP-binding 
cassette, sub-
family A 
(ABC1), 
member 4 GO:0005524 ATP binding 
   GO:0016887 ATPase activity 
   GO:0016021 
integral to 
membrane 
   GO:0016020 membrane 
   GO:0017111 
nucleoside-
triphosphatase 
activity 
   GO:0000166 nucleotide binding 
   GO:0050896 response to stimulus 
   GO:0006810 transport 
   GO:0006649 
phospholipid 
transfer to 
membrane 
   GO:0005548 
phospholipid 
transporter activity 
   GO:0004012 
phospholipid-
translocating 
ATPase activity 
   GO:0045494 
photoreceptor cell 
maintenance 
   GO:0007601 visual perception 
   GO:0042626 
ATPase activity, 
coupled to 
transmembrane 
movement of 
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substances 
   GO:0005887 
integral to plasma 
membrane 
MGI:1931123 Inpp4a 
inositol 
polyphosphate-
4-phosphatase, 
type I GO:0016787 hydrolase activity 
   GO:0016316 
phosphatidylinositol-
3,4-bisphosphate 4-
phosphatase activity 
   GO:0006798 
polyphosphate 
catabolic process 
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Gene ontology (GO) enrichment for the 17 genes was performed using both 
biological process and molecular function ontologies. Code written in MATLAB4 
grabbed GOids (biological process and molecular function) associated with each gene in 
the subset. To get a systems-level appreciation of these GOids, expression values of 
genes (in the original BVS analyzed dataset (P < 0.0055)) having membership to subset-
derived GOids (from the 17 gene subset) were grabbed and for each subset-derived GOid, 
the constitutive gene expression levels were averaged. For example, a biological process 
GOid of the 17 gene subset is ‘neutrophil chemotaxis.’ The gene expression profiles of 
all genes having membership to this GOid in the P < 0.0055 geneset were averaged. This 
provides information on the behavior of this ‘neutrophil chemotaxis’ GOid on the basis 
of its constituent genes’ expression profiles. Because the GOids have now been 
characterized with gene expression data (from their constituentive genes), the GOids can 
be visualized using heatmaps (Figure 15 and Figure 16). Furthermore, the 17 gene subset 
was able to correctly classify all control and flax pups as either a control or flax group 
member using a sampling based cross-validation procedure (
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Table 4). This analysis clearly correlates a decrease in expression of metabolism (energy) 
pathways with a reciprocal increase in cytokine and inflammatory (adipocytokine) 
signaling pathways. More specifically, upward programming was seen in chemotaxis, 
cell adhesion, cytokine and integrin pathways, T-cell and neutrophil activity, and 
cytolysis. Downward programming was seen chiefly in metabolic pathways. These 
findings suggest a developmental reprogramming of pathways in energy metabolism 
(decreased) and adipocytokine (increased) signaling, linked with the body weight defect 
between the flaxseed and control diets in mammary tissue.  
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Table 4. 100% classification rate for control and flax pups using the 17 gene subset 
Pup  Group Prediction 
0= control 
1 = flax 
Group Prediction 
0= control 
1 = flax 
Actual Group 
0= control 
1 = flax 
1 0.0304 0 0 
2 0.1214 0 0 
3 0.0358 0 0 
4 0.031 0 0 
5 0.0355 0 0 
6 0.0524 0 0 
7 0.0406 0 0 
8 0.0709 0 0 
9 0.0462 0 0 
10 0.0413 0 0 
11 0.0591 0 0 
12 0.0439 0 0 
13 0.9786 1 1 
14 0.9202 1 1 
15 0.9386 1 1 
16 0.9682 1 1 
17 0.9565 1 1 
18 0.8816 1 1 
19 0.85 1 1 
20 0.9779 1 1 
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Figure 15. Heatmap of biological process GOids from the 17 genesubset (from 
Bayesian variable selection representing the union of the top 10 models according to 
posterior density) 
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Figure 16. Heatmap of molecular function GOids from the 17 gene subset (from 
Bayesian variable selection representing the union of the top 10 models according to 
posterior density) 
 67 
 
 
Figure 17. Reciprocal behavior between energy and immune pathways 
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To further explore this reciprocal relationship MetaCoreTM V 5.0 analysis Suite 
from GeneGO Inc. was used to generate a genetic network of the adipocytokine pathway 
based on gene expression values of pathway genes in the entire microarray data set 
(Figure 18). A canonical representation of the adipocytokine pathway in KEGG was 
colored for expression levels using GeneSpring GX 7.3, Agilent Technologies Inc. 
(Figure 19).  
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Figure 18. Adipocytokine pathway 
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In the pathway, primarily immune-related and signaling pathways were up-
regulated, and in general, metabolic pathways were down-regulated (Figure 17). These 
are shown in Table 5 and Table 6 respectively. 
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Table 5. Up-regulated adipocytokine pathway genes 
Up   
Gene Symbol Protein Protein Name 
*JAK1 JAK1 Tyrosine-protein kinase JAK1 
SOCS3 SOC3  Supressor of Cytokine Signaling 
PKC-theta KPCT Protein kinase theta type 
AKT1 AKT1 RAC-alpha serine/threonine-protein kinase 
IKK-gamma IKKB 
Inhibitor of nuclear factor kappa-B kinase subunit 
beta 
IKK 
(cat)(IKBKG) NEMO NF-kappa-B essential modulator 
NFKBIE IKB NF-kappa-B inhibitor epsilon 
NFkb   
- RELA TF65 Transcription factor p65 
- RELB RELB transcription factor RelB 
- REL REL C-Rel proto-oncogene protein 
- NFKB2 NFKB2 Nuclear factor NF-kappa-B p100 subunit 
LTA TNF-beta Lymphotoxin-alpha precursor 
CD36 CD36 Platelet glycoprotein 4 
SLC2A2 
GTR2 
(GLUT2) 
Solute carrier family 2, facilitated glucose 
transporter member 2 
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Table 6. Down-regulated adipocytokine pathway genes 
Down   
Gene Symbol Protein Protein Name 
PPAR-
beta(delta)/RXR-
alpha PPARD Peroxisome proliferator-activated receptor cells 
IRS-4 IRS-4 Insulin-receptor substrate 4 
SLC2A1 
GTR2 
(GLUT1) 
Solute carrier family 2, facilitated glucose 
transporter member 1 
SLC2A4 
GTR4 
(GLUT4) 
Solute carrier family 2, facilitated glucose 
transporter member 4 
SLC2A5 
GTR5 
(GLUT5) 
Solute carrier family 2, facilitated glucose 
transporter member 4=5 
NPY1R NPY1R Neuropeptide Y receptor type 1 
RXRG RXRG Retinoic acid receptor RXR-gamma 
CPTII CPT2 
Carnitine O-palmitoyltransferase 2, mitochondrial 
precursor 
PPARGC1 
(PGC1-alpha) PRGC1 
Peroxisome proliferator-activated receptor gamma 
coactivator 1-alpha' 
AdipoR2 ADR2 Adiponectin receptor protein 2 
PCK1 PPCKC 
Phosphoenolpyruvate carboxykinase, cytosolic 
[GTP] 
CPT-1B CPT1B Carnitine O-palmitoyltransferase I, muscle isoform 
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Genespring (VERSION GX7.3, 5301 Stevens Creek Blvd, Santa Clara CA 95051, 
United States) was used to generate a canonical representation of the adipocytokine 
pathway using expression data via KEGG and is represented in Figure 19. Of the 22680 
Genbank Ids, 17487 and 21551 were mapped to unique gene IDs and EntrezGene IDs 
respectively. 
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Figure 19. Canonical adipocytokine pathway per KEGG using Genespring 
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5. DISCUSSION 
 
The adipocytokine pathway experienced a number of changes, with up and down-
regulated groups of genes showing displaying biological themes. Up-regulated genes 
primarily present protein kinase casacde and immune response pathways, whereas down-
regulated genes are indicative of metabolic pathways. These genes, their biological 
functions, and relevance to oncogenesis and obesity are included in Table 7 and Table 8.  
 More specifically, JAK-1 was independently implicated in potential relevance to 
high-fat fetal reprogramming by BVS and by pathway analysis, where the adipocytokine 
pathway displayed a large number of gene expression changes in constitutive genes. 
JAK-1 is a key component of the intracellular signaling cascade, and is an upstream 
effector of downstream transcript modulation of immune processes in particular. It is 
intimately involved in cytokine signaling and plays a role in initiaing such responses. 
JAK-1 stimulates stat5, a conventional prolactin signalling protein. Moreover, JAK-1 
also recuits new signals, such as stat3 and ERK. These are considered to be tumor-
promoting in breast tissue (Lee, Joung et al. 2006). It is interesting that JAK-1 retained 
such high expression in ex high-fat pups. This prolonged over-expression may effect 
many downstream changes, especially involving inflammatory processes, that are related 
to the pathogenesis of breast carinoma. As some of these genes and pathways have been 
implicated in promoting breast cancer development, JAK-1 inhibitors may be useful for 
breast cancer treatment. Another signal transduction element displaying over-expression 
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is protein kinase B (AKT-1), which is critical for transmitting growth signals. Also, 
AKT-1 is responsible for inactivating components of the apoptosis. Moreover, AKT-1 
expression have been implicated in accelerated breast tumourigenesis (Young, Nolte et 
al. 2008). Increased AKT-1 expression is also found with increased serum insulin levels, 
as insulin activates AKT-1 and 2.  High insulin levels will lead to insulin resistance. 
 Small heterodimer partner 2 (SHP-2) is a cytoplasmic SH2 domain and is 
involved in signaling pathways for growth factors and cytokines. This gene displayed up-
regulation in pups dosed with high-fat diets. Particularly, it is a critical intracellular 
regulator in mediating cell proliferation and differentiation. Given this function, and its 
positive relationship with lymph node metastasis and tumor grade, it has been suggested 
that SHP2 promotes breast oncogensis (Zhou, Coad et al. 2008). It is important to note 
that SHP2 effects downstream transciption changes of epidermal growth factor receptor 
(EGFR) and enhances EGFR activity during mouse growth and development (Qu, Yu et 
al. 1999). EGFR has been implicated in the breast carcinoma pathogensis. 
 AMP-activated protein kinase (AMPK) was significantly down-regulated. 
AMPK’s net effect is fatty acid oxiation, where lipogensis is inhibited. Interestingly, 
adiponectin expression is high in both control and dosed groups, where the dosed group 
had even higher expression, which is contrary to the observation that in obesity, 
adiponectin expression is typically markedly depressed. This observation is not well 
understood in infants and children, and as tissue sections were collected when mice were 
in puberty, the high adiponectin expression and obesity are probably not related. This is 
supported by the observation that adiponectin transcripts are over-expressed in 
adipogenic tissues (during development and differentiation). Adiponectin receptor 
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(ADIPOR-2) displayed marked decreased expression and is likely due to the diet-induced 
obesity and regulatory feedback from high expression of adiponectin. This would reduce 
adiponectin sensitivity, which would eventually lead to insulin resistance, a consequence 
of the adipocytokine pathway when showing decreased metabolic processes and 
increased cytokine/inflammatory pathways. 
 Neuropeptide Y receptor 2 (RPY-2R) expression was significatly increased, 
which effects decreased food intake (appetite) and adipogenesis. These, as a result of 
diet-induced obesity, also lead to insulin resistance. Most of the genes showing 
significant down-regulation are related to metabolic processes. CPT-1 was significantly 
down-regulated, and is responsible for fatty acid oxidation and transport of long chain 
fatty acids across the mitochondrial membrance (binds them to carnitine). Also, acetyl-
CoA carboxylase 2 (ACC-2) is another key regulator of mitochondrial fat oxidation that 
displayed downward expression in the experimental groups. It has been noted in the 
litertaure that ACC-2 negative mice have a normal lifespan, and that ACC-2 targeted 
inhibition may be a viable therapeutic option for the treatment of obesity and type 2 
diabetes mellitus.  
These metabolic processes do not demonstrate the relationship to breast 
carcinogensis as do the signal tranduction and regulatory immune processes that 
underwent significant upward cellular response reprogramming. However, they do have a 
strong relationship with obesity, and more significantly, diabetes mellitus. Generally, this 
is a consequence of the increase in insulin resistance, which is the net outcome of the 
upwardly expressed signalling and immune processes and downwardly expressed 
metabolic processes in the adipocytokine pathways.  It is important to note that these 
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changes reflect cellular responses and have been observed effecting transcription activity 
in the mammary tissue of female offspring via microarray profiling.  
Although these changes were represented in the adipocytokine pathway, this is 
not the only pathway involved. These changes in the adipocytokine pathway are only an 
indication of statistical/bioinformatic programming taken place. Furthermore, the changes 
in the adipocytokine pathway may be interpreted from different persectives. For example, 
the changes seen per this analysis may comprise some portion of a larger system-wide 
regulatory change, or there may have been changes in cellularity that express this 
particular pathway. These potential changes in cellularity may reflect an imbalance 
cellularity of parenchyma and adipose tissues in the mammary gland. 
Overall, inflammatory processes were statistically up-regulated, and metabolic 
processes were statistically down-regulated in the mammary gland. As shown earlier, 
some immune components are significantly upstream and effect many downstream 
transcript changes. It was observed that these changes in inflammatory processes were 
maintained in ex-fat period until 10 wks and may reflect a possible permanent immune 
dysregulation. The increased pup weight for ex-fat diets is likely due to increased 
adipogenesis because of the nature of fatty diet. It is important to note that the mammary 
glands themselves were not weighed. However, it is likely they experienced a weight 
defect in accordance with body weight trajectory. 
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Table 7. Processes and cancer implications for up-regulated genes of Adipocytokine 
pathway 
Up-regulated 
Genes   
Name 
Biological 
Process Information 
Protein kinase C 
theta (PKC) 
signal 
transduction 
• Members of the PKC family are divided into three groups 
based on their molecular structures and activating 
mechanisms: 1) Conventional PKC (alpha, beta, and 
gamma) requiring calcium, phosphatidylserine (PS), and 
diacylglycerol (DG) for activation; 2) novel PKC (sigma, 
epsilon, eta, and theta) activated independent of calcium; 
and 3) Atypical PKC (zeta and lamda), which are 
independent of both calcium and DG. High-level expression 
of PKC-theta was found in skeletal muscle, lung, T cells, 
and brain, and minimal expression in cardiac muscle, 
placenta, and liver. PKC theta is a autophosphorylated 
protein kinase. 
Protein kinase B 
(AKT-1) 
signal 
transduction 
• Mice lacking Akt1 display a 25% reduction in body mass, 
indicating that Akt1 is critical for transmitting growth 
promoting signals, most likel via the igf1 receptor. Mice 
lacking atk1 are also resistant to cancer: they experience 
considerable delay in tumor growth initiated by the large T 
antigen or the Neu oncogene. 
• inactivates components of the apoptotic machinery. 
• Mammary carcinoma: Expression of activated Akt1 in 
MMTV-c-ErbB2 mice accelerates tumourigenesis with a 
reduced requirement for signalling through the EGFR 
family, as well as a reduced requirement for a subset of 
downstream signaling molecules with a metabolic shift in 
the tumours from bitransgenic mice. (Young, Nolte et al. 
2008) 
Suppressor of 
cytokine 
signaling 3 
(SOCS 3) 
cytokine-
inducible 
negative 
regulators of 
cytokine 
signaling 
• The expression of this gene is induced by various 
cytokines, including IL6, IL10, and interferon (IFN)-
gamma. The protein encoded by this gene can bind to JAK2 
kinase, and inhibit the activity of JAK2 kinase. Studies of 
the mouse counterpart of this gene suggested the roles of 
this gene in the negative regulation of fetal liver 
hematopoiesis, and placental development.  
•  Elevated expression of SOCS genes is a specific lesion of 
breast-cancer cells that may confer resistance to 
proinflammatory cytokines and trophic factors, by shutting 
down STAT1/STAT5 signaling that mediate essential 
functions in the mammary gland. (Evans, Yu et al. 2006) 
Janus kinase 1 
(JAK1) 
Signal 
transduction 
• upstream effector of downstream transcript modulation 
(immune processes) 
• Signaling of type 1 and 2 cytokines (IL-2, IL-4, gp130, 
CNTF-R, NNT-1R, Leptin-R, IFN-alpha,beta,gamma 
interferon’s, IL-10) 
• In breast cancer cells, Jak1 not only stimulates 
conventional prolactin signaling via proteins such as Stat5, 
but also that Jak1 recruited new signals, especially Stat3 
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and ERK. Stat3 and ERK typically are considered tumor-
promoting, so inhibitors of Jak1 may become useful in 
breast cancer treatment. 
• Results that may provide the basis for identifying another 
mechanism of breast tumorigenesis via the JAK [?]/STAT 
pathway in hypoxia.(Lee, Joung et al. 2006) 
Small 
heterodimer 
partner 2 (SHP-
2) 
member of the 
nuclear receptor 
family of 
intracellular 
transcription 
factors 
• SHP-2, a cytoplasmic SH2 domain containing protein 
tyrosine phosphatase, is involved in the signaling pathways 
of a variety of growth factors and cytokines. Recent studies 
have clearly demonstrated that this phosphatase plays an 
important role in transducing signal relay from the cell 
surface to the nucleus, and is a critical intracellular 
regulator in mediating cell proliferation and differentiation 
(Qu 2000)  
• Given SHP2's positive role in cell growth, transformation 
and stem cell survival, the positive relationship of its 
overexpression to lymph node metastasis, nuclear 
accumulation of hormone receptors and higher tumour 
grade suggests that SHP2 promotes breast oncogenesis 
(Zhou, Coad et al. 2008)  
• Feeds into MARK signaling pathway 
• Effects Downstream transcription of epidermal growth 
factor receptor (EGF-R) => Thus, we provide biological 
evidence here that protein-tyrosine phosphatase SHP-2 acts 
to enhance information flow from the EGF-R in mouse 
growth and development (Qu, Yu et al. 1999) 
HUGE RELATIONSHIP TO BREAST CANCER 
Neuropeptide Y 
2 (NPY-2) 
peptide 
neurotransmitter 
found in the 
brain and 
autonomic 
nervous system 
• Decrease in food intake, increase in adipogenesis 
IKappa B 
Kinase gamma 
(IKK-gamma) 
upstream NF-κB 
signal 
transduction 
cascade 
• Regulatory subunit of IKK complex, which activates NF-
KappaB. IKKbeta (and IKKgamma) are essential for rapid 
NF-kappaB activation by proinflammatory signaling 
cascades, such as those triggered by tumor necrosis factor 
alpha (TNFalpha) or lipopolysaccharide (LPS) (Hacker and 
Karin 2006) 
• IKK/NF kappa B system is generally overexpressed in 
breast cancer cells and there is heterogeneity in expression 
levels of individual members between different cell lines 
 
Tumor necrosis 
factor beta 
(lymphotoxin 
beta) (TNF-b) 
Immune 
response 
(cytokine) 
• TNF-beta is involved in the regulation of various 
biological processes including cell proliferation, 
differentiation, apoptosis, lipid metabolism, coagulation, 
and neurotransmission. TNF-beta is secreted as a soluble 
polypeptide, but can form heterotrimers with lymphotoxin-
beta, which effectively anchors the TNF-beta to the cell 
surface. TNF-beta is cytotoxic to a wide range of tumor 
cells.   
peroxisome 
proliferator-
activated 
receptors beta-
delta (PPAR-
nuclear hormone 
receptors that 
bind peroxisome 
proliferators and 
control the size 
• differentiation, lipid accumulation, directional sensing, 
polarization, and migration in keratinocytes  
• After fertilisation, PPAR-gamma and PPAR-beta/delta are 
essential regulators of placentation and the subsequent 
development of key metabolic tissues such as skeletal 
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bd) and number of 
peroxisomes 
produced by 
cells 
muscle and adipose cells (Rees, McNeil et al. 2008) 
 
Glucose 
Transporter 2 
(GLUT-2) 
carrier protein 
and gene which 
is involved in 
passive glucose 
transport  
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Table 8. Processes and cancer implications for down-regulated genes of 
Adipocytokine pathway 
Down-regulated 
Genes   
Name 
Biological 
Process Information 
Insulin receptor 
substrate (IRS) 
elicits insulin’s 
actions 
 
Phosphoenolpyruvat
e carboxykinase  
(PEPCK) 
Gluconeogensis  
Adiponectin 
receptor 2 (ADIPO-
R(2)) 
receptor for 
adiponectin 
• Both of the receptors activate AMPK and PPAR 
alpha metabolic pathways leading to an increase in 
fatty acid oxidation, glucose uptake and a decreased 
rate of gluconeogenesis, thus enhancing insulin 
sensitivity. Moreover effects of adiponectin mimic 
many metabolic actions of insulin such as 
augmenting blood flow and glucose disposal in NO-
dependent manner. The precise mechanism of 
regulation of plasma adiponectin level is unknown. 
Recently the mechanism of transcriptional activation 
of adiponectin gene via PPAR gamma was 
described. Its level seems to be decreased by 
TNFalfa and beta-adrenergic agonists (Szopa, 
Malczewska-Malec et al. 2004) 
• Obesity decreased expression levels of 
AdipoR1/R2, thereby reducing adiponectin 
sensitivity, which finally leads to insulin resistance, 
the so-called "vicious cycle." (Kadowaki and 
Yamauchi 2005) 
 
AMP-activated 
protein kinase 
(AMPK) 
 • Recently, low adiponectin levels are significantly 
associated with an increased breast cancer risk 
(Takahata, Miyoshi et al. 2007) 
• The net effect of AMPK activation is stimulation of 
hepatic fatty acid oxidation and ketogenesis, 
inhibition of cholesterol synthesis, lipogenesis, and 
triglyceride synthesis, inhibition of adipocyte 
lipolysis and lipogenesis, stimulation of skeletal 
muscle fatty acid oxidation and muscle glucose 
uptake, and modulation of insulin secretion by 
pancreatic beta-cells. 
Acetyl-CoA 
carboxylase 2 
(ACC-2)  
 • key regulator of mitochondrial fat oxidation 
• Taken together with previous work demonstrating 
that Acc2(-/-) mice have a normal lifespan, these 
data suggest that Acc2 inhibition is a viable 
therapeutic option for the treatment of obesity and 
type 2 diabetes (Choi, Savage et al. 2007) 
GLUT 1,4,5 carrier protein and 
gene which is 
involved in 
passive glucose 
transport  
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CPT-1, 2  • transport of long chain fatty acids across the 
membrane by binding them to carnitine. 
• Genes for fatty acid oxidation 
(Sampath, Miyazaki et al. 2007) 
PGC-1alpha  • regulates the genes involved in energy metabolism 
• The protection from obesity involves elevated 
oxygen consumption/energy expenditure and 
increased fatty acid oxidation in adipose tissue with 
concurrent increased mitochondria genesis, up-
regulation of PGC-1alpha and UCP-2 [?], and down-
regulation of perilipin [?]. 
(Bansode, Huang et al. 2008) 
PPCKC  • main control point for the regulation of 
gluconeogenesis 
NPY-1R  • Y1-R-/- mice showed a moderate obesity and mild 
hyperinsulinemia without hyperphagia. Although 
there was some variation between males and 
females, typical characteristics of Y1-R-/- mice 
include: greater body weight (females more than 
males), an increase in the weight of white adipose 
tissue (WAT) (approximately 4-fold in females), an 
elevated basal level of plasma insulin (approximately 
2-fold), impaired insulin secretion in response to 
glucose administration, and a significant changes in 
mitochondrial uncoupling protein (UCP) gene 
expression (up-regulation of UCP1 in brown adipose 
tissue and down-regulation of UCP2 in 
WAT).(Kushi, Sasai et al. 1998) 
RXRG   • involved in mediating the antiproliferative effects 
of retinoic acid (RA).  
• Retinoid X receptor gamma-deficient mice have 
increased skeletal muscle lipoprotein lipase activity 
and less weight gain when fed a high-fat diet. 
IRS-4  • Protein phosphatase 4 interacts with and down-
regulates insulin receptor substrate 4 following 
tumor necrosis factor-alpha 
stimulation.(Mihindukulasuriya, Zhou et al. 2004) 
• Acts as an interface between multiple growth factor 
receptors possessing tyrosine kinase activity, such as 
insulin receptor, IGF1R and FGFR1, and a complex 
network of intracellular molecules containing SH2 
domains. 
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 Our studies aim to identify new biomarker leads for altered developmental (fetal) 
programming that correlate with early susceptibility to breast tumors. Such biomarker 
leads may translate into molecular diagnostics for pre-malignant foci in human patients. 
Comparative bioinformatics can reveal how closely the murine data reflects the human 
response. These scenarios can be enhanced in the applications of prior knowledge of 
established biomarkers for breast cancer (eg, ER-alpha, PrgR, EgfR, Her2-Neu, Cox2) 
drawn from national databases, statistical reductions in the high-dimension data from 
cellular microgenomics profiles, and the generation of new hypotheses regarding how 
developmental programming of large genetic regulatory networks in specific precursor 
target cell subpopulations might initiate and propagate changes in cell states leading to 
breast cancer. 
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6. SUMMARY AND CONCLUSIONS 
 
 
In general, this study was performed as an exploratory study with gestational-
lactational exposure of Harlan mice to high-fat diets switched at 6-weeks postnatal. The 
results can be summarized as follows. First, maternal high-fat diet altered growth 
trajectories and gene expression in the mammary gland at 10 weeks. Second, flaxseed oil 
diet (high in omega-3) had a lasting effect on body weight compared to a diet with corn 
oil (high in omega-6). Third, the genomic response signatures based on a comprehensive 
microarray analysis suggested that the changes were associated with a decrease in 
expression of energy metabolism pathways and a reciprocal increase in cytokine and 
inflammatory signaling pathways. Fourth, the changes in gene expression may reflect 
imbalance of cellularity of parenchymal and adipose tissue that may influence the risk of 
breast cancer. 
We may conclude from this analysis that prenatal and perinatal exposure to a 
high-fat (24%) diet had a long-term effect on postnatal body weights versus the regular 
low-fat (5%) diet and that the latent effect persisted longer when the high-fat diet was 
provided by flaxseed oil versus corn oil. Computational analysis demonstrated a decrease 
in expression of energy pathways with a reciprocal increase in cytokine and inflammatory 
signaling pathways. Computational pathway analysis using GeneGo software showed 
these changes were reflected in the adipocytokine pathway, where the protein kinase 
cascade and immune response pathways displayed upward programming, and metabolic 
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processes displayed downward programming.  Janus kinase 1 (JAK-1) and carnitine O-
palmitoyltransferase I (CPT-1) expression levels were particularly affected. Because of 
these changes, we may conclude that maternal dietary fat exposure significantly 
influenced gene expression associated with metabolic programming and signaling 
networks in the mammary gland of female offspring. In addition, the adipocytokine 
pathway may be a sensitive trigger to dietary changes and this may influence or enhance 
activation of an immune response, a key event in cancer development. Together, these 
data suggest that maternal intake of a high-fat diet may predispose their offspring to 
breast cancer. 
More specifically, due to experimental design, it may be stated that omega-3 
PUFAs causally affect mouse adolescent obesity and immune and metabolic 
reprogramming of the mammary gland.  Potential clinical implications of a enriched 
omega-3 diet are epigenetic risk factors for breast cancer via dysregulatory inflammatory 
changes and for type 2 diabetes via insulin resistance stemming from adolescent obesity. 
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Environmental Protection Agency, Research Triangle Park, NC.
Summer 2008 Computational Toxicology
National Center for Computational Toxicology
Perceptor: Thomas Knudsen, PhD
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University of Tennessee Knoxville, TN.
2005 - 2006 Graduate Research Assistant Dept. of Nuclear Engineering
Perceptors: Wes Hines, PhD, Lawrence Townsend, PhD
Publications
1. Gregory Rempala, Caleb D. Bastian . "Modified CART with comparison of variable
selection techniques in high-dimensional data." Publication Pending 2008.
2. Thomas B. Knudsen, Amar V. Singh, Caleb D. Bastian, M Luijten, A de
Vries, and AH Piersma. "Altered Developmental (Fetal) Programming of the Mouse
Mammary Gland in Female O!spring Following Maternal Dietary Exposures." Publication
Pending 2008.
3. Amar V. Singh, Eric C. Rouchka, Greg A. Rempala, Caleb D. Bastian, and
Thomas B. Knudsen. "Integrative Database Management for Mouse Development: Sys-
tem and Concepts." Birth Defects Research (Part C). 81:1-19, 2007.
4. J. Wesley Hines, Peter Groer, Belle Upadhyaya, Alexander Usynin, and
Caleb D. Bastian. "Improved Probability of Failure Analysis Using On-Line Equip-
ment Condition Monitoring Data." EPRI, Palo Alto, CA, The University of Tennessee :
2007.
5. Caleb D. Bastian. "Analysis of large solar particle events with extraction of doses
per energy contribution with implications for space radiation shielding." The University of
Tennessee, 2005.
Presentations
2008 Thesis defense (M.S.) - Oral Biology - November 21
Altered Developmental Programming of the Mouse Mammary Gland in
Female O!spring Following Perinatal Dietary Exposures.
2008 Research! Louisville, University of Louisville, October 21 (Poster).
Altered Developmental Programming of the Mouse Mammary Gland in
Female O!spring Following Perinatal Dietary Exposures.
2008 American Association of Dental Research (AADR), Dallas, TX, April 4.
Systems-Based Analysis of Developmental Programming of the Mammary Gland using
Bayesian Variable Selection.
2008 ULSD Student Convention, Louisville, KY, February 6 (Poster).
Microarray-derived Biomarkers: Identification and Diagnostic Implications
2007 Research! Louisville, University of Louisville, October 16 (Poster).
Systems-Based Analysis of Developmental Programming of the Mammary Gland using
Bayesian Variable Selection.
2007 CGeMM Computational Biology Core, University of Louisville, September 17.
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Systems-Based Analysis of Developmental Programming of the Mammary Gland using
Bayesian Variable Selection.
2006 American Nuclear Society (student), Rensselaer Polytechnic Institute, March 31.
Improved Probability of Failure (POF) Analysis using On-Line Equipment Condition
Monitoring Data.
Honors
2008 Research! Louisville (health sciences research competition) - 2nd place
Altered Developmental Programming of the Mouse Mammary Gland in
Female O!spring Following Perinatal Dietary Exposures.
2008 National Cancer Institute Research Grant (Renewal)(R25 CA044789)
2008 Honored (DMD) - Pharmacology and Toxicology
2007 ULSD Student Convention Clinical Research Poster Competition - 3rd place
Microarray-derived Biomarkers: Identification and Diagnostic Implications
2007 Research! Louisville (health sciences research competition) - 1st place
Systems-Based Analysis of Developmental Programming of Mammary Gland
using Bayesian Variable Selection
2007 National Cancer Institute Research Grant (R25 CA044789)
2007 Honored (DMD) - Biochemistry, Microbiology, Research Seminar
2006 Most Outstanding Undergraduate in College of Engineering
2006 Phi Mu Alpha School of Music Scholastic Award
2006 Speaker at Chancellor’s Banquet
2005 - 2006 Principal Oboe - Symphonic Band
2004 - 2006 Tau Beta Pi - Member
2005 Rhodes Scholarship Applicant
2005 UT/Oak Ridge National Lab Chancellors Honors Research Internship
2005 Passed Engineer in Training/Fundamentals of Engineering exam in Tennessee,
National Council of Examiners for Engineering & Surveying (NCEES)
2004 Junior Outstanding Academic Achievement Award in Nuclear Engineering
2004 Pianist for All-Sing Competition - Phi Mu Alpha & Phi Mu
2003 Head of programming team in building optical character recognition
software in MATLAB
2003 - 2005 Principal Oboe - Wind Ensemble
2002 - 2003 Principal Oboe - Symphonic Band
2002 Valedictorian, White House High School, TN.
Scholarships
2008 Graduate Research Assistantship (UofL: College of Business)
2007 School of Dentistry Scholarship
2006 Graduate Research Assistantship (UT: Dept. of Nuclear Engineering)
2005 - 2006 National American Nuclear Society Scholarship
2004 - 2006 National Academy for Nuclear Training Scholarship
2002 - 2006 Bicentennial Scholarship
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2002 - 2006 Ned Ray McWherter Scholarship
2002 - 2006 Henry A. Haenseler Engineering Scholarship
2002 - 2006 Elizabeth Buford Shepherd Scholarship
2002 - 2006 Band Scholarship
2004 - 2005 Nuclear Engineering/Health Physics Scholarship program
through MUSC/SCUREF
2004 Department of Energy Fellowship
2002 - 2004 Pasqua Nuclear Engineering Scholarship
2002 - 2004 Alumni Valedictorian Scholarship
Extracurricular Activies and Organizations
2008 - Present UofL Task Force for Tuition and Fees - health-science campus student representative
2007 - Present Alpha Omega Dental Fraternity
2007 - Present Strength Training
2006 - Present Student American Dental Association
2006 - Present Louisville American Student Dental Association
2007 Kosair Children’s Hospital Pediatric Dentistry Integration Project
2007 Performer - "A Convocation of Thanks" - Cadaver Appreciation Ceremoney
2007 Microbiology & Immunology Class Representative
2006 Junior Recital - Oboe
2005 - 2006 Mills Music Mission
2005 - 2006 Symphonic Band
2004 - 2006 UTK American Nuclear Society - Member
2004 - 2006 National American Nuclear Society
2003 - 2006 Phi Mu Alpha - Member, Secretary 2005
2002 - 2006 Oboe lessons
2005 Academic A!airs Committee Member (Student Government Association)
May 2005 Study Abroad - Cambridge, UK (Emmanuel College)
"From Medieval to Cathedral"
2003 - 2005 Wind Ensemble
2004 Pep Band
2003 Piano lessons
2003 Intramural Flag Football
2003 SGA Campaign - Engineering Senator
2002 - 2003 Symphonic Band
Work Experience
2007 DMD tutor - Physiology
2004 Private artists - sanding, grinding, and general shaping of metals
for large statuary
2002 Smith Travel Research Internship (Henderonsville, TN)
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Database Management - Full-time
Computing Experience
Operating Systems: Windows, UNIX, OS-X
Programming Languages: C, FORTRAN 77/90
Technical Software: R, MATLAB, Maple, Mathematica, WinBUGS, SCALE, EViews
Other Skills
Musical Instruments: Piano - 17 yrs, primarily compositions by Chopin
Oboe - 14 yrs, 17th through 20th century compositions
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